US20150190257A1 - Stent graft delivery systems and associated methods - Google Patents

Stent graft delivery systems and associated methods Download PDF

Info

Publication number
US20150190257A1
US20150190257A1 US14/498,808 US201414498808A US2015190257A1 US 20150190257 A1 US20150190257 A1 US 20150190257A1 US 201414498808 A US201414498808 A US 201414498808A US 2015190257 A1 US2015190257 A1 US 2015190257A1
Authority
US
United States
Prior art keywords
stent graft
stent
sheath
distal
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/498,808
Inventor
Andrew H. Cragg
Isa Rizk
Stephen Sosnowski
John Logan
Mahmood Dehdashtian
Pedram Nourian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altura Medical Inc
Original Assignee
Altura Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/466,044 external-priority patent/US20090287145A1/en
Priority claimed from US12/628,131 external-priority patent/US20100305686A1/en
Application filed by Altura Medical Inc filed Critical Altura Medical Inc
Priority to US14/498,808 priority Critical patent/US20150190257A1/en
Assigned to SILICON VALLEY BANK reassignment SILICON VALLEY BANK SECURITY AGREEMENT Assignors: ALTURA MEDICAL, INC.
Assigned to SILICON VALLEY BANK reassignment SILICON VALLEY BANK SECURITY AGREEMENT Assignors: ALTURA MEDICAL, INC.
Assigned to ALTURA MEDICAL, INC. reassignment ALTURA MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOURIAN, PEDRAM, SOSNOWSKI, STEPHEN, LOGAN, JOHN, RIZK, ISA, CRAGG, ANDREW H., DEHDASHTIAN, MAHMOOD
Assigned to ALTURA MEDICAL, INC. reassignment ALTURA MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOURIAN, PEDRAM, SOSNOWSKI, STEPHEN, LOGAN, JOHN, RIZK, ISA, CRAGG, ANDREW H., DEHDASHTIAN, MAHMOOD
Publication of US20150190257A1 publication Critical patent/US20150190257A1/en
Assigned to ALTURA MEDICAL, INC. reassignment ALTURA MEDICAL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: SILICON VALLEY BANK
Assigned to ALTURA MEDICAL, INC. reassignment ALTURA MEDICAL, INC. RELEASE Assignors: SILICON VALLEY BANK
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A61F2/9661Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod the proximal portion of the stent or stent-graft is released first
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A61F2002/9665Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0033Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0034D-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts

Definitions

  • the present technology relates to treatment of abdominal aortic aneurysms. More particularly, the present technology relates to stent graft delivery systems and associated methods.
  • An aneurysm is a dilation of a blood vessel of at least 1.5 times above its normal diameter.
  • a dilated vessel forms a bulge known as an aneurysmal sac that can weaken vessel walls and eventually rupture.
  • Aneurysms are most common in the arteries at the base of the brain (i.e., the Circle of Willis) and in the largest artery in the human body, the aorta.
  • the abdominal aorta spanning from the diaphragm to the aortoiliac bifurcation, is the most common site for aortic aneurysms.
  • Such abdominal aortic aneurysms typically occur between the renal and iliac arteries, and are presently one of the leading causes of death in the United States.
  • AAAs The two primary treatments for AAAs are open surgical repair and endovascular aneurysm repair (EA/AR).
  • Surgical repair typically includes opening the dilated portion of the aorta, inserting a synthetic tube, and closing the aneurysmal sac around the tube.
  • AAA surgical repairs are highly invasive, and are therefore associated with significant levels of morbidity and operative mortality.
  • surgical repair is not a viable option for many patients due to their physical conditions.
  • EVAR vascular endovascular aneurysm repair
  • EVAR typically includes inserting a delivery catheter into the femoral artery, guiding the catheter to the site of the aneurysm via X-ray visualization, and delivering a synthetic stent graft to the AAA via the catheter.
  • the stent graft reinforces the weakened section of the aorta to prevent rupture of the aneurysm, and directs the flow of blood through the stent graft away from the aneurismal region. Accordingly, the stent graft causes blood flow to bypass the aneurysm and allows the aneurysm to shrink over time.
  • stent grafts are made from surgical grade materials that are inherently thick and rigid, and therefore associated delivery systems typically have a size of approximately 20 Fr (i.e., approximately 6.7 mm in diameter) and greater. This size can be intrusive when placed through small iliac vessels, and accordingly cut-down procedures are used to introduce the delivery catheter. Cut-down procedures result in longer and more uncomfortable healing processes than if the stent graft was implanted using a smaller, percutaneously deliverable system.
  • reducing the diameter of the delivery catheter e.g., to allow for percutaneous implantation
  • FIG. 1A is a partial cut-away, isometric view of a modular stent graft system configured in accordance with an embodiment of the present technology.
  • FIG. 1B is an isometric view of the modular stent graft system of FIG. 1A in a sealed configuration in accordance with an embodiment of the present technology.
  • FIG. 2 is an enlarged view of a superior portion of a stent graft having anchoring barbs configured in accordance with an embodiment of the present technology.
  • FIGS. 3-6 illustrate various stages of deploying a stent graft from a delivery system configured in accordance with an embodiment of the present technology.
  • FIGS. 7A and 7B are side views of a stent graft and a stent frame, respectively, configured in accordance with embodiments of the present technology.
  • FIGS. 8 and 9 are enlarged views of a superior portion of a stent frame having medial turns configured in accordance with an embodiment of the present technology.
  • FIGS. 10 and 11 are partial side views of two stent frames interlocked by medial turns in accordance with another embodiment of the present technology.
  • FIG. 12 is an enlarged side view of a portion of a cover for a stent graft configured in accordance with an embodiment of present technology.
  • FIG. 13 is an exploded isometric view of a stent graft delivery system configured in accordance with another embodiment of the present technology.
  • FIG. 14 is an enlarged exploded isometric view of a distal portion of the stent graft delivery system of FIG. 13 .
  • FIG. 15 is an isometric view of the stent graft delivery system if FIGS. 13 and 14 assembled in accordance with an embodiment of the present technology.
  • FIGS. 16-18 are enlarged, isometric views of a stent graft delivery system as it is being pushed through an introducer valve in accordance with an embodiment of the present technology.
  • a stent graft delivery system includes proximal and distal catheters that can be individually manipulated to deploy a stent graft.
  • stent graft delivery systems configured in accordance with the present technology can include a stent cover that houses at least a portion of a stent graft prior to and during delivery of the stent graft to the aneurysm.
  • the stent cover maintains the low profile of the stent graft such that the stem graft can fit into smaller sized delivery introducers (e.g., 14 Fr, 12 Fr, 10 Fr introducers), and also provides low stern deployment forces that enable control and precision during deployment.
  • smaller sized delivery introducers e.g., 14 Fr, 12 Fr, 10 Fr introducers
  • FIGS. 1A-18 Certain specific details are set forth in the following description and in FIGS. 1A-18 to provide a thorough understanding of various embodiments of the technology. For example, many embodiments are described below with respect to the delivery of stent grafts that at least partially repair AAAs. In other applications and other embodiments, however, the technology can be used to repair aneurysms in other portions of the vasculature. Other details describing well-known structures and systems often associated with stent grafts and associated delivery devices and procedures have not been set forth in the following disclosure to avoid unnecessarily obscuring the description of the various embodiments of the technology. A person of ordinary skill in the art, therefore, will accordingly understand that the technology may have other embodiments with additional elements, or the technology may have other embodiments without several of the features shown and described below with reference to FIGS. 1A-18 .
  • distal and proximal can reference a relative position of the portions of an implantable stent graft device and/or a delivery device with reference to an operator
  • Proximal refers to a position closer to the operator of the device
  • distal refers to a position that is more distant from the operator of the device.
  • FIGS. 1A and 1B are isometric views of a modular stent graft system 100 (“system 100 ”) configured in accordance with an embodiment of the present technology.
  • the system 100 can include separate stent grafts 102 (identified individually as a first stent graft 102 a and a second stent graft 102 b ) that can be coupled, mated, or otherwise substantially sealed together in situ.
  • Each stent graft 102 can include a braided or integrated frame 104 (“frame 104 ”) and an at least substantially impermeable sleeve or cover 106 (“cover 106 ”) extending over at least a portion of the frame 104 .
  • the frame 104 and the cover 106 of an individual stent graft 102 can form a discrete lumen 116 through which blood can flow to bypass an aneurysm.
  • the stent grafts 102 are generally delivered separately and positioned independently across the aneurysm.
  • each stent graft 102 includes a superior portion 108 and an inferior portion 110 .
  • the superior portion 108 can include a convexly curved outer wall 112 and a septal wall 114 .
  • the septal wall 114 can be substantially flat such that the superior portion 108 forms a “D” shape at a superior portion of the lumen 116 .
  • the septal wall 114 can be convexly curved with a larger radius of curvature than the outer wall 112 such that the superior portion 108 forms a complex ellipsoid having another D-shaped cross-section at the superior portion of the lumen 116 .
  • the superior portion 108 can have asymmetrical shapes or other suitable cross-sectional configurations that can mate with each other in the septal region and mate with an arterial wall around the periphery of the outer wall 112 .
  • the inferior portion 110 can have a circular cross-sectional shape, an elliptical shape, a rectangular shape, an asymmetrical shape, and/or another suitable cross-sectional shape for an inferior portion of the lumen 116 .
  • the superior portions 108 of the stent grafts 102 are mated together and at least substantially sealed along the septal walls 114 (e.g., as shown in FIG. 113 ) within the aorta above an aneurysm.
  • the superior portion 108 can be approximately 2-4 cm in length to adequately fix the outer walls 112 to the arterial walls such that they are at least substantially sealed together. In other embodiments, the superior portion 108 can be longer or shorter.
  • the inferior portions 110 can extend through an inferior portion of the aneurysm and into corresponding iliac arteries to bypass the aneurysm, in another embodiment, one or both inferior portions 110 can terminate within the aneurysm to form what is known to those skilled in the art as a “gate,” and limbs (not shown) can be attached to the proximal ends of the inferior portions 110 and extended into the iliac arteries to bypass the aneurysm.
  • the frames 104 have bare end portions 118 (identified individually as first end portions 118 a and second end portions 118 b ) that extend beyond the covers 106 .
  • the first end portion 118 a can extend distally from the superior terminus of the cover 106
  • the second end portion 118 b can extend proximally from the inferior terminus of the cover 106 .
  • the end portions 118 can be trumpeted or flared to interface with the arterial walls of the aorta and/or the iliac arteries. This can promote cell ingrowth that strengthens the seal between the endograft devices 102 and the adjacent arteries.
  • the end portions 118 can also increase the available structure for securing the stent graft 102 to the artery and increase the surface area of the covers 106 for sealably fixing the stent grafts 102 to arterial walls. This decreases the precision necessary to position the stent grafts 102 and increases the reliability of the implanted system 100 .
  • a short infrarenal aortic neck e.g., less than 2 cm
  • a short infrarenal aortic neck generally requires precise placement of the stent grafts 102 to preserve blood flow to the renal arteries while still providing enough surface area for the stent grafts 102 to be properly affixed with the aorta.
  • the first end portions 118 a can be placed at the entrance of the renal arteries to allow lateral blood flow into the renal arteries and provide a larger structure for fixing the stent grafts 102 to the arterial wall and a larger sealing area with the arterial wall.
  • the end portions 118 can also provide accessible sites for recapture (e.g., by guidewires, bead and collet, etc.) that enhance the accuracy of positioning the stent grafts 102 across the aneurysm.
  • each stent graft 102 can be delivered independently to an aneurysmal region in a low-profile configuration.
  • the low-profile configuration has a first cross-sectional dimension and a first length that can facilitate percutaneous endovascular delivery of the system 100 .
  • the stent grafts 102 can expand (e.g., manually or self-expand) to an expanded configuration (e.g., shown in FIGS. 1A and 1B ),
  • the expanded configuration can have a second cross-sectional dimension greater than the first cross-sectional dimension and a second length less than the first length.
  • the septal walls 114 ( FIG. 1A ) of the stent grafts 102 can be forced against one another.
  • the forces between the opposing septal walls 114 form a septum 120 in which the septal walls 114 are at least substantially sealed together to prevent blood from flowing between the stent grafts 102 and into the aneurysm.
  • the texture (e.g., ribbing) on the covers 106 can mate at the septum 120 to further strengthen the seal between the septal walls 114 .
  • the texture of the cover 106 on the outer walls 112 can interface with the adjacent vessel walls to strengthen the seal around the periphery of the stent grafts 102 .
  • a single stent graft can be used to direct blood flow away from a diseased aneurismal portion of a blood vessel through the stent graft,
  • a stent graft can includes features generally similar to the features of the stent grafts 102 of the dual stent graft system 100 described above with reference to FIGS. 1A and 1B .
  • the stem graft 202 includes two anchoring barbs 222 .
  • the stent graft 202 can include one anchoring barb 222 or more than two anchoring barb 222 positioned on the superior and/or inferior portions of the stent graft 202 .
  • the anchoring barbs 222 can be separate elements that are attached to the frame 104 ,
  • the anchoring barbs 222 can be small wires that are fastened to the frame 104 by winding another wire (e.g., a Nitinol wire) around the anchoring barbs 222 and an adjacent wire 224 of the frame 104 .
  • the anchoring barbs are integrally formed with the wires 224 used in the braid of the frame 104 .
  • Such integrated anchoring barbs 222 can deploy (i.e., project outwardly) and retract in a manner responsive to at least one of elongation, shortening, contraction, and dilation of the frame 104 .
  • FIGS. 3-6 are top views a delivery system 300 in various stages of deploying a stent graft and configured in accordance with an embodiment of the present technology.
  • the delivery system 300 is shown deploying the stent graft 202 of FIG. 2 .
  • the delivery system 300 may be used to deliver any suitable stent graft.
  • the delivery system 300 can include a proximal sheath 326 that covers a proximal portion of the stent graft 202 (not shown) and a distal sheath 328 that covers a distal portion of the stent frame 202 .
  • the proximal sheath 326 and the distal sheath 328 may cover contiguous portions of the stent frame, leave a medial portion uncovered, and/or overlap to fully cover the stent graft 202 .
  • the delivery system 300 can include more than two delivery sheaths, each configured to cover at least a portion of a stent graft
  • the delivery system 300 is can deliver the stent graft 202 to a deployment location in the vasculature of a patient.
  • the delivery system 300 may be delivered percutaneously into a vessel (e.g., inserted in the femoral artery) and guided to the site of an abdominal aortic aneurysm.
  • the proximal sheath 326 can be retracted relative to the stent graft 202 and relative to the distal sheath 328 , thereby uncovering and deploying at least a proximal portion of the stent graft 202 .
  • the distal sheath 328 may continue to cover the distal portion of the stern graft 202 while the proximal sheath 326 is retracted.
  • the distal sheath 328 may cover a portion of the stent graft 202 including the anchoring barbs 222 ( FIG. 6 ) while other portions of the stent graft 202 are deployed.
  • anchoring barbs 222 to remain unanchored to the surrounding tissue (e.g., the arterial walls) during deployment of other portions of the stent graft 202 not including anchoring barbs 222 such that the anchoring barbs 222 do not injure the surrounding tissue during lateral or longitudinal adjustments to the position of the stent graft 202 .
  • the distal sheath 328 can be advanced relative to the stent graft 202 to deploy the distal portion of the stent graft 2 . 02 and the anchoring barbs 222 attached thereto.
  • the distal sheath 328 is operable by a user via a central wire 330 (e.g., as shown in FIGS. 3 , 4 , and 5 ).
  • the central wire 330 can be made from a material that is flexible enough to navigate tortuous anatomy (e.g., the iliac arteries and/or other portions of the vasculature), but still stiff enough to translate advancement thereof by a user to the distal sheath 328 , such as stainless steel, Nitinol, and/or other suitable materials.
  • the central wire 330 can he positioned through the lumen formed at least in part by the proximal sheath 326 and the stent graft 202 .
  • the central wire 330 can be used to remove the distal sheath 328 and any other distal portions of the delivery system 300 through the central lumen of the stent graft 202 ,
  • the delivery system 300 can include features that enhance expansion and/or constriction of stent grafts (e.g., to achieve full expansion of the two D-shaped stent grafts 102 of FIGS. 1A and 1B ),
  • the delivery system 300 may include spur-shaped elements on telescoping coaxial tubes to engage portions (e.g., proximal and/or distal portions) of a stent graft while it is constrained within one or both of the sheaths 326 and 328 .
  • Engaging portions of the stent graft can provide axial control at one or more points along the stent graft.
  • the delivery system 300 can engage an aortic or distal end portion of a stent graft (i.e., the portion of the stent graft eventually deployed within the aorta) to stabilize it, while another portion of the delivery system 300 engages an iliac or proximal end portion of the stent graft to move it proximally and constrain or constrict the stent graft 202 as it is exposed from the sheaths 326 and 328 .
  • This coordinated motion can be used to achieve a controlled braid angle of the frame as the stent graft is exposed.
  • the delivery system 300 can also maintain the position of a stent graft relative to the deployment location (e.g., an AAA).
  • the delivery system 300 can include engagement features that connect to other portions of the stent graft.
  • the deployment system 300 can be used to deliver an expandable stent graft, such as the expandable stent grafts 102 and 202 discussed above with reference to FIGS. 1A-2 .
  • one or more sheaths e.g., the proximal sheath 326 and/or the distal sheath 328
  • the stent graft can be unsheathed such that it expands and shortens in length to a deployed configuration.
  • the sheath may be removed from the proximal or distal end of the stent graft as described above.
  • the delivery system 300 includes a gear arrangement 331 ( FIG. 3 ) between or connecting one or more sheaths (e.g., the proximal sheath 326 , the distal sheath 328 ) to a stent graft positioned therein.
  • a gear arrangement 331 FIG. 3
  • the gear arrangement 331 may be configured to advance the stent graft while simultaneously retracting the sheath relative to the stent graft such that an end portion (e.g., a proximal end portion or a distal end portion) of the stent graft is held in a position (e.g., at a desired location relative to the aneurysm) while the sheath is removed and the stent graft transitions from the sheathed configuration to the deployed configuration.
  • an end portion e.g., a proximal end portion or a distal end portion
  • the gear arrangement 331 may be configured to retract the stent graft (e.g., rather than the sheath) while simultaneously advancing the sheath relative to the stent graft such that one of the proximal or distal end portions of the stem graft is held in place while transitioning the stent graft from the sheathed configuration to the deployed configuration.
  • the portion of the stent graft that includes the anchoring barbs can be maintained at a single position while the stent graft transitions from the sheathed configuration to the deployed configuration.
  • anchoring barbs are deployed before or during stent graft deployment, holding the stent graft in such a fixed location reduces, mitigates, or eliminates damage to the arterial walls caused by the anchoring barbs during deployment of the remainder of the stent graft (e.g., distally directed force as the sheath is removed from the stent graft).
  • the gear arrangement 331 can have a gear ratio configured to correspond to a ratio of the shortened length of the stent graft to the elongated length of the stent graft (i.e., the length of the stent graft in the sheathed configuration versus the deployed configuration). This allows the gear arrangement 331 to compensate for foreshortening of the stent graft during deployment.
  • the gear arrangement 331 may have a gear ratio corresponding to a ratio of the shortened length to the elongated length as it relates to the amount of the stent graft that is being deployed (e.g., when the amount is less than all of the stent frame).
  • a single wire 724 can be interwoven to form a braid pattern and looped at the end portions of the frame 704 to form turns 725 (e.g., by looping the wire partially around a pin or other structure) and reverse direction to continue weaving along the length of the frame 704 toward the opposite end portion.
  • the intersections of the wire 724 are not welded or otherwise fixed together such that they remain unbound.
  • each area of the frame 704 influences the radial expansion or contraction of an adjacent area of the frame 704 .
  • the frame 704 can be configured such that the wires 724 do not terminate at the end portions of the braid structure (i.e., at the turns 725 ) where stress concentration may be highest.
  • each wire 724 in the braid structure can overlap an opposing end of the same wire or an adjacent wire along the length of the braid structure, can be crimped in suitable splice tube, and/or otherwise affixed to a medial portion of the braid structure.
  • the frame 704 may be constructed from a variety of resilient metallic materials, polymeric materials (e.g., polyethylenes, polypropylenes, Nylons, PTF Es, and the like), and composites of materials.
  • the wires 724 can be made from biocompatible stainless steels, highly elastic metallic alloys, and bioconmatible shape setting materials (e.g., Nitinol) that exhibit shape memory properties.
  • the frame 704 can be constrained (e.g., elongated and contracted) to fit within a small sheath of a delivery system (e.g., the proximal sheath 326 and/or the distal sheath 328 of the delivery system 300 of FIGS. 3-6 ).
  • a delivery system e.g., the proximal sheath 326 and/or the distal sheath 328 of the delivery system 300 of FIGS. 3-6 .
  • each longitudinal segment of the braided wire 724 e.g., between opposing turns 725
  • the frame 704 has varying cross-sectional dimensions or shapes (e.g., a D-shaped superior portion and a circular inferior portion as shown in FIGS.
  • the frame 704 can be formed in two stages: (1) the wire 724 can be braided on a dual-diameter mandrel, and (2) a portion of the braided wire 724 can be reshaped on a D-shaped mandrel. This allows the wire 724 to maintain uniform end-to-end distances while conforming to the D-shaped cross section.
  • FIGS. 8 and 9 are enlarged views of a distal portion of a stent frame 804 configured in accordance with another embodiment of the present technology.
  • the stent frames 804 include features generally similar to the features of the frames discussed above. However, as shown in FIGS. 8 and 9 , the stent frames 804 include medial turns 840 that are bent or otherwise formed to extend or flare radially outward away from the center lumen of the stent frame 804 beyond what would otherwise be defined as the body of the stent frame 804 . As discussed in more detail below, the angle ⁇ at which the medial turns 840 project relative to the body of the stent frame 804 may be defined according to desired attributes.
  • the medial turns 840 can provide a hook or other type of engagement feature that catches on wire diamonds formed by the braid pattern of another stent frame.
  • FIGS. 10 and 11 are side views of a first stent frame 1004 a having medial turns 840 that are disposed substantially concentrically within a second braided stent frame 1004 b.
  • the first stent frame 1004 a can be expanded within the second stent frame 1004 b such that the medial turns extend through the openings of the second stent frame 1004 b. This resists rotation and axial movement of the two stent frames 1004 with respect to one another.
  • one or more of the stent frames 1004 can include two sets of medial turns 804 with opposing orientations such that blow flow and other forces in either direction on the stent frames 1004 cause one or both sets of medial turns 804 to embed more deeply into the accompanying stent frame 1004 .
  • Such interlocking stent frames 1004 e.g., with one or more sets of medial turns 804 ) may be used to create a continuous flow path through different portions of vascular anatomy.
  • a first stent frame 1004 a can he placed within an iliac artery or limb and connected to the second stent frame 1004 b placed above or within an AAA.
  • the cover 1206 can be made from a substantially impermeable, biocompatible, and flexible material.
  • the cover 1206 can be made from synthetic polymers, polyurethanes, silicone materials, polyurethane/silicone combinations, rubber materials, woven and non-woven fabrics such as Dacron®, fluoropolymer compositions such as a polytetrafluoroethylene (PTFE) materials, expanded PTFE materials (ePTFE) such as TEFLON®, GORE-TEX®, SOFTFORM®, IMPRA®, and/or other suitable materials.
  • PTFE polytetrafluoroethylene
  • ePTFE expanded PTFE materials
  • the cover 1206 can be made from a material that is sufficiently porous to permit ingrowth of endothelial cells. Such a porous material can provide more secure anchorages of stent grafts and potentially reduce flow resistance, sheer forces, and leakage of blood around the stent grafts.
  • the cover 1206 can be attached to as stent frame using a suture material.
  • the zigzagged end portions of the cover 1206 can be sutured to the stent frame.
  • the suture material may be distributed along the axial length of the stent frame (e.g., following diamond braid pattern) such that the suture material is not distributed in one cross section of the stent graft.
  • the stent graft 1302 can be only partially sheathed, leaving a portion of the stent graft 1302 (e.g., 3 inches of the stent graft 1302 ) exposed.
  • the stent cover 1352 can be placed over the stern graft 1302 after it is loaded in the delivery device (see, e.g., FIG. 15 ).
  • the stent cover 1352 sheathes the stent graft 1302 and a portion of the delivery device during shipping and storage, and assists in introducing the stent graft 1302 through an introducer valve and sheath during clinical use.
  • the stent cover 1352 can be made from high density polyethylene (HDPE), low density polyethylene (LDPE), fluorinated ethylene propylene (FEP), polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), combinations thereof, arid/or other suitable materials.
  • the stent cover 1352 can include a liner along the inner diameter made of a material having a low coefficient of friction, such as FEP and PTFE. This can reduce frictional forces as the stent graft 1302 is loaded into the stent cover 1352 (e.g., during manufacturing) and during clinical use of the delivery system 1300 .
  • the funnel shape of the flared proximal end portion 1358 can facilitate loading the stent graft 1302 into the stent cover 1352 by gradually compressing fabric (e.g., Dacrone) or other materials on the outer surface of the stent graft 1302 (e.g., a ribbed cover as shown in FIG. 12 ) as it is inserted into the stent cover 1352 .
  • fabric e.g., Dacrone
  • other materials on the outer surface of the stent graft 1302 e.g., a ribbed cover as shown in FIG. 12
  • the stent cover 1352 can maintain the sheathed size of the stent graft 1302 before deployment.
  • the stent cover 1352 can be positioned over the stent graft 1302 during manufacture to prevent an outer layer of accordion-like folded Dacron®, PTFE, and/or other folded fabric from unfolding or unwrapping, over time. Accordingly, the stent cover 1352 maintains a low profile of the stent graft 1302 such that it can be introduced into a small introducer sheath (e.g., a 10 Fr, 12 Fr, 14 Fr sheath), and therefore allows for percutaneous delivery of the stent graft 1302 .
  • a small introducer sheath e.g., a 10 Fr, 12 Fr, 14 Fr sheath
  • FIGS. 16-18 are enlarged, isometric views of various stages of the delivery system 1300 as it is being pushed through an introducer valve 1660 in accordance with an embodiment of the present technology.
  • the delivery system 1300 can be inserted into the introducer valve 1660 and introducer sheath 1662 via the distal delivery component 1354 ( FIG. 16 ), and is pushed through the introducer valve 1660 into the introducer sheath 1662 ( FIG. 1 ).
  • the stent cover 1352 provides sheathing for the stent graft as it is being delivered to the introducer valve 1660 such that the stent graft 1302 maintains a low profile.
  • the stent graft 1302 is, therefore, partially exposed (e.g., approximately 3 inches of the stent graft 1302 ) as it passes through the introducer valve 1660 , but the low profile provided by the stent cover 1352 allows it to be introduced into a small introducer sheath (e.g., a 14 Fr introducer sheath, a 10 Fr introducer sheath, etc.).
  • a small introducer sheath e.g., a 14 Fr introducer sheath, a 10 Fr introducer sheath, etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Prostheses (AREA)

Abstract

Stent graft delivery systems are disclosed herein. In several embodiments, a stent graft delivery system can include a stent graft having a proximal portion and a distal portion, a proximal sheath and a distal sheath. The proximal sheath can be configured to cover the proximal portion of the stent graft, and the distal sheath can be configured to cover the distal portion of the stent graft. The proximal sheath and the distal sheath can be independently removable from respective ends of the stent graft such that the proximal and distal portions of the stent graft are independently deployable.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 13/237,822 filed. Sep. 20, 2011, entitled “STENT GRAFT DELIVERY SYSTEMS AND ASSOCIATED METHODS,” and claims priority to and the benefit of U.S. Provisional Patent Application No. 61/384,669, filed Sep. 20, 2010, entitled “STENT GRAFT DELIVERY SYSTEMS AND METHODS,” and U.S. Provisional Patent Application No. 61/527,064, filed Aug. 24, 2011, entitled “ENDOVASCULAR STENT GRAFT DELIVERY SYSTEMS AND ASSOCIATED METHODS,” both of which are incorporated herein by reference in their entireties.
  • The following patent applications are also incorporated by reference herein in their entireties:
  • (a) U.S. patent application Ser. No. 12/466,044, filed May 14, 2009;
  • (b) U.S. patent application Ser. No. 12/628,131, filed Nov. 30, 2009;
  • (c) U.S. Provisional Pat. App. No. 61/265,713, filed Dec. 1, 2009;
  • (d) U.S. Provisional Pat. App. No. 61/293,581, filed Jan. 11, 2010; and
  • (e) U.S. Provisional Pat. App. No. 61/320,646, filed Apr. 2, 2010.
  • TECHNICAL FIELD
  • The present technology relates to treatment of abdominal aortic aneurysms. More particularly, the present technology relates to stent graft delivery systems and associated methods.
  • BACKGROUND
  • An aneurysm is a dilation of a blood vessel of at least 1.5 times above its normal diameter. A dilated vessel forms a bulge known as an aneurysmal sac that can weaken vessel walls and eventually rupture. Aneurysms are most common in the arteries at the base of the brain (i.e., the Circle of Willis) and in the largest artery in the human body, the aorta. The abdominal aorta, spanning from the diaphragm to the aortoiliac bifurcation, is the most common site for aortic aneurysms. Such abdominal aortic aneurysms (AAAs) typically occur between the renal and iliac arteries, and are presently one of the leading causes of death in the United States.
  • The two primary treatments for AAAs are open surgical repair and endovascular aneurysm repair (EA/AR). Surgical repair typically includes opening the dilated portion of the aorta, inserting a synthetic tube, and closing the aneurysmal sac around the tube. Such AAA surgical repairs are highly invasive, and are therefore associated with significant levels of morbidity and operative mortality. In addition, surgical repair is not a viable option for many patients due to their physical conditions.
  • Minimally invasive endovascular aneurysm repair (EVAR) treatments that implant stent grafts across aneurysmal regions of the aorta have been developed as an alternative or improvement to open surgery. EVAR typically includes inserting a delivery catheter into the femoral artery, guiding the catheter to the site of the aneurysm via X-ray visualization, and delivering a synthetic stent graft to the AAA via the catheter. The stent graft reinforces the weakened section of the aorta to prevent rupture of the aneurysm, and directs the flow of blood through the stent graft away from the aneurismal region. Accordingly, the stent graft causes blood flow to bypass the aneurysm and allows the aneurysm to shrink over time.
  • Conventional stent grafts are made from surgical grade materials that are inherently thick and rigid, and therefore associated delivery systems typically have a size of approximately 20 Fr (i.e., approximately 6.7 mm in diameter) and greater. This size can be intrusive when placed through small iliac vessels, and accordingly cut-down procedures are used to introduce the delivery catheter. Cut-down procedures result in longer and more uncomfortable healing processes than if the stent graft was implanted using a smaller, percutaneously deliverable system. However, reducing the diameter of the delivery catheter (e.g., to allow for percutaneous implantation) increases the force required to unsheathe and expose the stent graft. This increased three also reduces control and precision during deployment, making it more difficult for a physician to implant the stent graft and potentially causing damage to the stent graft and/or the surrounding vessel walls.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a partial cut-away, isometric view of a modular stent graft system configured in accordance with an embodiment of the present technology.
  • FIG. 1B is an isometric view of the modular stent graft system of FIG. 1A in a sealed configuration in accordance with an embodiment of the present technology.
  • FIG. 2 is an enlarged view of a superior portion of a stent graft having anchoring barbs configured in accordance with an embodiment of the present technology.
  • FIGS. 3-6 illustrate various stages of deploying a stent graft from a delivery system configured in accordance with an embodiment of the present technology.
  • FIGS. 7A and 7B are side views of a stent graft and a stent frame, respectively, configured in accordance with embodiments of the present technology.
  • FIGS. 8 and 9 are enlarged views of a superior portion of a stent frame having medial turns configured in accordance with an embodiment of the present technology.
  • FIGS. 10 and 11 are partial side views of two stent frames interlocked by medial turns in accordance with another embodiment of the present technology.
  • FIG. 12 is an enlarged side view of a portion of a cover for a stent graft configured in accordance with an embodiment of present technology.
  • FIG. 13 is an exploded isometric view of a stent graft delivery system configured in accordance with another embodiment of the present technology.
  • FIG. 14 is an enlarged exploded isometric view of a distal portion of the stent graft delivery system of FIG. 13.
  • FIG. 15 is an isometric view of the stent graft delivery system if FIGS. 13 and 14 assembled in accordance with an embodiment of the present technology.
  • FIGS. 16-18 are enlarged, isometric views of a stent graft delivery system as it is being pushed through an introducer valve in accordance with an embodiment of the present technology.
  • DETAILED DESCRIPTION
  • The present technology is directed toward stent graft delivery systems and associated methods. In several embodiments, for example, a stent graft delivery system includes proximal and distal catheters that can be individually manipulated to deploy a stent graft. In further embodiments, stent graft delivery systems configured in accordance with the present technology can include a stent cover that houses at least a portion of a stent graft prior to and during delivery of the stent graft to the aneurysm. The stent cover maintains the low profile of the stent graft such that the stem graft can fit into smaller sized delivery introducers (e.g., 14 Fr, 12 Fr, 10 Fr introducers), and also provides low stern deployment forces that enable control and precision during deployment.
  • Certain specific details are set forth in the following description and in FIGS. 1A-18 to provide a thorough understanding of various embodiments of the technology. For example, many embodiments are described below with respect to the delivery of stent grafts that at least partially repair AAAs. In other applications and other embodiments, however, the technology can be used to repair aneurysms in other portions of the vasculature. Other details describing well-known structures and systems often associated with stent grafts and associated delivery devices and procedures have not been set forth in the following disclosure to avoid unnecessarily obscuring the description of the various embodiments of the technology. A person of ordinary skill in the art, therefore, will accordingly understand that the technology may have other embodiments with additional elements, or the technology may have other embodiments without several of the features shown and described below with reference to FIGS. 1A-18.
  • In this application, the terms “distal” and “proximal” can reference a relative position of the portions of an implantable stent graft device and/or a delivery device with reference to an operator, Proximal refers to a position closer to the operator of the device, and distal refers to a position that is more distant from the operator of the device.
  • Selected Stent Graft Structures
  • FIGS. 1A and 1B are isometric views of a modular stent graft system 100 (“system 100”) configured in accordance with an embodiment of the present technology. The system 100 can include separate stent grafts 102 (identified individually as a first stent graft 102 a and a second stent graft 102 b) that can be coupled, mated, or otherwise substantially sealed together in situ. Each stent graft 102, for example, can include a braided or integrated frame 104 (“frame 104”) and an at least substantially impermeable sleeve or cover 106 (“cover 106”) extending over at least a portion of the frame 104. The frame 104 and the cover 106 of an individual stent graft 102 can form a discrete lumen 116 through which blood can flow to bypass an aneurysm. In operation, the stent grafts 102 are generally delivered separately and positioned independently across the aneurysm.
  • As shown in FIGS. 1A and 1B, each stent graft 102 includes a superior portion 108 and an inferior portion 110. The superior portion 108 can include a convexly curved outer wall 112 and a septal wall 114. As shown in FIG. 1A, the septal wall 114 can be substantially flat such that the superior portion 108 forms a “D” shape at a superior portion of the lumen 116. In other embodiments, the septal wall 114 can be convexly curved with a larger radius of curvature than the outer wall 112 such that the superior portion 108 forms a complex ellipsoid having another D-shaped cross-section at the superior portion of the lumen 116. In further embodiments, the superior portion 108 can have asymmetrical shapes or other suitable cross-sectional configurations that can mate with each other in the septal region and mate with an arterial wall around the periphery of the outer wall 112. The inferior portion 110 can have a circular cross-sectional shape, an elliptical shape, a rectangular shape, an asymmetrical shape, and/or another suitable cross-sectional shape for an inferior portion of the lumen 116.
  • The superior portions 108 of the stent grafts 102 are mated together and at least substantially sealed along the septal walls 114 (e.g., as shown in FIG. 113) within the aorta above an aneurysm. In some embodiments, the superior portion 108 can be approximately 2-4 cm in length to adequately fix the outer walls 112 to the arterial walls such that they are at least substantially sealed together. In other embodiments, the superior portion 108 can be longer or shorter. In one embodiment in accordance with the technology, the inferior portions 110 can extend through an inferior portion of the aneurysm and into corresponding iliac arteries to bypass the aneurysm, in another embodiment, one or both inferior portions 110 can terminate within the aneurysm to form what is known to those skilled in the art as a “gate,” and limbs (not shown) can be attached to the proximal ends of the inferior portions 110 and extended into the iliac arteries to bypass the aneurysm.
  • In the embodiment shown in FIGS. 1A and 1B, the frames 104 have bare end portions 118 (identified individually as first end portions 118 a and second end portions 118 b) that extend beyond the covers 106. As shown in FIGS. 1A and 1B, the first end portion 118 a can extend distally from the superior terminus of the cover 106, and the second end portion 118 b can extend proximally from the inferior terminus of the cover 106. In some embodiments, the end portions 118 can be trumpeted or flared to interface with the arterial walls of the aorta and/or the iliac arteries. This can promote cell ingrowth that strengthens the seal between the endograft devices 102 and the adjacent arteries.
  • The end portions 118 can also increase the available structure for securing the stent graft 102 to the artery and increase the surface area of the covers 106 for sealably fixing the stent grafts 102 to arterial walls. This decreases the precision necessary to position the stent grafts 102 and increases the reliability of the implanted system 100. For example, a short infrarenal aortic neck (e.g., less than 2 cm) generally requires precise placement of the stent grafts 102 to preserve blood flow to the renal arteries while still providing enough surface area for the stent grafts 102 to be properly affixed with the aorta. In the embodiment shown in FIGS. 1A and 1B, however, the first end portions 118 a can be placed at the entrance of the renal arteries to allow lateral blood flow into the renal arteries and provide a larger structure for fixing the stent grafts 102 to the arterial wall and a larger sealing area with the arterial wall. The end portions 118 can also provide accessible sites for recapture (e.g., by guidewires, bead and collet, etc.) that enhance the accuracy of positioning the stent grafts 102 across the aneurysm.
  • During deployment of the system 100, each stent graft 102 can be delivered independently to an aneurysmal region in a low-profile configuration. The low-profile configuration has a first cross-sectional dimension and a first length that can facilitate percutaneous endovascular delivery of the system 100. Because each stent graft 102 extends around only a portion of the vessel periphery, the individual stent grafts 102 can be constricted (i.e., radially collapsed) to a smaller diameter than conventional AAA stent grafts with a single superior portion that extends around the complete periphery of the vessel wall, in some embodiments, for example, each of the stent grafts 102 can have a diameter of 25 mm in the expanded configuration, and can be constricted to a diameter of 4 mm in the low-profile configuration to be percutaneously deployed across the aneurysm through a 12 Fr catheter. Additionally, because each stent graft 102 can be delivered independently, the end portions 118 and fenestrations can facilitate staggering the stent grafts 102 to accommodate asymmetrical anatomies,
  • At a target site in the aneurysmal region, the stent grafts 102 can expand (e.g., manually or self-expand) to an expanded configuration (e.g., shown in FIGS. 1A and 1B), The expanded configuration can have a second cross-sectional dimension greater than the first cross-sectional dimension and a second length less than the first length. In the expanded configuration shown in FIG. 1B, the septal walls 114 (FIG. 1A) of the stent grafts 102 can be forced against one another. When in situ within the aorta, the forces between the opposing septal walls 114 form a septum 120 in which the septal walls 114 are at least substantially sealed together to prevent blood from flowing between the stent grafts 102 and into the aneurysm. Additionally, as shown in FIG. 1B, the texture (e.g., ribbing) on the covers 106 can mate at the septum 120 to further strengthen the seal between the septal walls 114. Similarly, the texture of the cover 106 on the outer walls 112 can interface with the adjacent vessel walls to strengthen the seal around the periphery of the stent grafts 102.
  • In other embodiments, a single stent graft can be used to direct blood flow away from a diseased aneurismal portion of a blood vessel through the stent graft, Such a stent graft can includes features generally similar to the features of the stent grafts 102 of the dual stent graft system 100 described above with reference to FIGS. 1A and 1B. For example, the single stent graft can include the intergrated frame 104 and the ribbed cover 106 that expand radially from a low-profile configuration used during delivery to an expanded configuration at the site of the aneurysm, In this embodiment, however, the superior portion of the stent graft can have a substantially circular cross-sectional shape to seal against the circumference of the aorta.
  • FIG. 2 is an enlarged isometric view of a superior portion 208 of a stent graft 202 configured in accordance with another embodiment of the present technology, The stent graft 202 includes features generally similar to the features of the stent grafts 102 described above with reference to FIGS. 1A and 1B, For example, the stem graft 202 includes the integrated frame 104 and the cover 106. The stent graft 202 can be one of a pair of D-shaped stent grafts as described above or a circular stent graft.
  • As shown in FIG. 2, the stent graft 202 further includes one or more anchoring barbs 222 that project radially outward from the frame 104 to engage the interior surfaces of arterial walls. The anchoring barbs 222 can be “V” shaped projections as shown, hooks, and/or other shapes that can penetrate into the arterial walls to resist migration of the stent graft 202 within the artery and reduce the likelihood of endoleaks between the outer wall of the stent graft 202 and the arterial wall, The anchoring barbs 222 can be made from resilient metallic materials, polymeric materials (e.g., polyethylenes, polypropylenes, Nylons, PTFEs), and/or other suitable materials that can anchor the stent graft 202 to arterial walls. In the illustrated embodiment, the stem graft 202 includes two anchoring barbs 222. In other embodiments, however, the stent graft 202 can include one anchoring barb 222 or more than two anchoring barb 222 positioned on the superior and/or inferior portions of the stent graft 202.
  • In various embodiments, the anchoring barbs 222 can be separate elements that are attached to the frame 104, For example, the anchoring barbs 222 can be small wires that are fastened to the frame 104 by winding another wire (e.g., a Nitinol wire) around the anchoring barbs 222 and an adjacent wire 224 of the frame 104. In other embodiments, the anchoring barbs are integrally formed with the wires 224 used in the braid of the frame 104. Such integrated anchoring barbs 222 can deploy (i.e., project outwardly) and retract in a manner responsive to at least one of elongation, shortening, contraction, and dilation of the frame 104. For example, the anchoring barbs 222 can be deployed when the frame 104 expands and can retract when the frame 104 constricts, Accordingly, the anchoring barbs 222 do not inhibit movement of the stent graft 202 during delivery in the low-profile configuration.
  • Stent Graft Delivery Systems
  • FIGS. 3-6 are top views a delivery system 300 in various stages of deploying a stent graft and configured in accordance with an embodiment of the present technology. In the illustrated embodiment, the delivery system 300 is shown deploying the stent graft 202 of FIG. 2. However, the delivery system 300 may be used to deliver any suitable stent graft. Referring to FIG. 3, the delivery system 300 can include a proximal sheath 326 that covers a proximal portion of the stent graft 202 (not shown) and a distal sheath 328 that covers a distal portion of the stent frame 202. The proximal sheath 326 and the distal sheath 328 may cover contiguous portions of the stent frame, leave a medial portion uncovered, and/or overlap to fully cover the stent graft 202. In other embodiments, the delivery system 300 can include more than two delivery sheaths, each configured to cover at least a portion of a stent graft
  • In operation, the delivery system 300 is can deliver the stent graft 202 to a deployment location in the vasculature of a patient. For example, the delivery system 300 may be delivered percutaneously into a vessel (e.g., inserted in the femoral artery) and guided to the site of an abdominal aortic aneurysm. As shown in FIGS. 4 and 5, upon arrival at the deployment location, the proximal sheath 326 can be retracted relative to the stent graft 202 and relative to the distal sheath 328, thereby uncovering and deploying at least a proximal portion of the stent graft 202.
  • As shown in FIGS. 4 and 5, in various embodiments, the distal sheath 328 may continue to cover the distal portion of the stern graft 202 while the proximal sheath 326 is retracted. For example, the distal sheath 328 may cover a portion of the stent graft 202 including the anchoring barbs 222 (FIG. 6) while other portions of the stent graft 202 are deployed. This allows the anchoring barbs 222 to remain unanchored to the surrounding tissue (e.g., the arterial walls) during deployment of other portions of the stent graft 202 not including anchoring barbs 222 such that the anchoring barbs 222 do not injure the surrounding tissue during lateral or longitudinal adjustments to the position of the stent graft 202.
  • As shown in FIG. 6, once the stent graft 202 is positioned in the desired location, the distal sheath 328 can be advanced relative to the stent graft 202 to deploy the distal portion of the stent graft 2.02 and the anchoring barbs 222 attached thereto. In the illustrated embodiment, the distal sheath 328 is operable by a user via a central wire 330 (e.g., as shown in FIGS. 3, 4, and 5). The central wire 330 can be made from a material that is flexible enough to navigate tortuous anatomy (e.g., the iliac arteries and/or other portions of the vasculature), but still stiff enough to translate advancement thereof by a user to the distal sheath 328, such as stainless steel, Nitinol, and/or other suitable materials. To navigate the vasculature, the central wire 330 can he positioned through the lumen formed at least in part by the proximal sheath 326 and the stent graft 202. Once the distal portion of the stent graft 202 is deployed, the central wire 330 can be used to remove the distal sheath 328 and any other distal portions of the delivery system 300 through the central lumen of the stent graft 202,
  • In various aspects of the present technology, the delivery system 300 may be used to deploy the stent graft 202 and/or other stent grafts using various other methods. For example, in one embodiment, a distal portion of a stent graft can be deployed before a proximal portion of the stent frame. As another example, one of the sheaths (e.g., the distal sheath 328 or the proximal sheath 326) can be only partially removed from a stent graft before adjusting the other sheath. In further embodiments, the delivery system 300 can include additional sheaths to further provide controllable deployment of portions of a stent graft.
  • In further aspects of the present technology, the delivery system 300 can include features that enhance expansion and/or constriction of stent grafts (e.g., to achieve full expansion of the two D-shaped stent grafts 102 of FIGS. 1A and 1B), For example, the delivery system 300 may include spur-shaped elements on telescoping coaxial tubes to engage portions (e.g., proximal and/or distal portions) of a stent graft while it is constrained within one or both of the sheaths 326 and 328. Engaging portions of the stent graft can provide axial control at one or more points along the stent graft. For example, the delivery system 300 can engage an aortic or distal end portion of a stent graft (i.e., the portion of the stent graft eventually deployed within the aorta) to stabilize it, while another portion of the delivery system 300 engages an iliac or proximal end portion of the stent graft to move it proximally and constrain or constrict the stent graft 202 as it is exposed from the sheaths 326 and 328. This coordinated motion can be used to achieve a controlled braid angle of the frame as the stent graft is exposed. By grasping the distal and/or proximal end portions of the stent graft, the delivery system 300 can also maintain the position of a stent graft relative to the deployment location (e.g., an AAA). In other embodiments, the delivery system 300 can include engagement features that connect to other portions of the stent graft.
  • In still further aspects of the present technology, the deployment system 300 can be used to deliver an expandable stent graft, such as the expandable stent grafts 102 and 202 discussed above with reference to FIGS. 1A-2. For example, one or more sheaths (e.g., the proximal sheath 326 and/or the distal sheath 328) can cover the stent graft during delivery such that it is in a low profile, sheathed configuration with an elongated length, and during deployment the stent graft can be unsheathed such that it expands and shortens in length to a deployed configuration. The sheath may be removed from the proximal or distal end of the stent graft as described above.
  • In yet another aspect of the present technology, the delivery system 300 includes a gear arrangement 331 (FIG. 3) between or connecting one or more sheaths (e.g., the proximal sheath 326, the distal sheath 328) to a stent graft positioned therein. The gear arrangement 331 may be configured to advance the stent graft while simultaneously retracting the sheath relative to the stent graft such that an end portion (e.g., a proximal end portion or a distal end portion) of the stent graft is held in a position (e.g., at a desired location relative to the aneurysm) while the sheath is removed and the stent graft transitions from the sheathed configuration to the deployed configuration. In other embodiments, the gear arrangement 331 may be configured to retract the stent graft (e.g., rather than the sheath) while simultaneously advancing the sheath relative to the stent graft such that one of the proximal or distal end portions of the stem graft is held in place while transitioning the stent graft from the sheathed configuration to the deployed configuration.
  • When the stent graft includes anchoring barbs (e.g., the stent graft 202 of FIG. 2 with anchoring barbs 222), the portion of the stent graft that includes the anchoring barbs can be maintained at a single position while the stent graft transitions from the sheathed configuration to the deployed configuration. When the anchoring barbs are deployed before or during stent graft deployment, holding the stent graft in such a fixed location reduces, mitigates, or eliminates damage to the arterial walls caused by the anchoring barbs during deployment of the remainder of the stent graft (e.g., distally directed force as the sheath is removed from the stent graft).
  • In various embodiments, the gear arrangement 331 can have a gear ratio configured to correspond to a ratio of the shortened length of the stent graft to the elongated length of the stent graft (i.e., the length of the stent graft in the sheathed configuration versus the deployed configuration). This allows the gear arrangement 331 to compensate for foreshortening of the stent graft during deployment. In other embodiments, the gear arrangement 331. may have a gear ratio corresponding to a ratio of the shortened length to the elongated length as it relates to the amount of the stent graft that is being deployed (e.g., when the amount is less than all of the stent frame).
  • Selected Embodiments of Stent Frames and Covers
  • FIGS. 7A and 7B are side views of a stent graft 702 and a stent frame 704, respectively, configured in accordance with embodiments of the present technology. The stent graft 702 and stent frame 704 can include features generally similar to the features of the stent grafts 102 and 202 described above with reference to FIGS. 1A-2. Referring to FIG. 7B, the frame 704 can have a braided structure made from one or more continuous interwoven wires 724 that provide continuous integrated support longitudinally along the length of the frame 704. For example, a single wire 724 can be interwoven to form a braid pattern and looped at the end portions of the frame 704 to form turns 725 (e.g., by looping the wire partially around a pin or other structure) and reverse direction to continue weaving along the length of the frame 704 toward the opposite end portion. In various embodiments, the intersections of the wire 724 are not welded or otherwise fixed together such that they remain unbound. As such, each area of the frame 704 influences the radial expansion or contraction of an adjacent area of the frame 704. in further embodiments, the frame 704 can be configured such that the wires 724 do not terminate at the end portions of the braid structure (i.e., at the turns 725) where stress concentration may be highest. Instead, the ends of each wire 724 in the braid structure can overlap an opposing end of the same wire or an adjacent wire along the length of the braid structure, can be crimped in suitable splice tube, and/or otherwise affixed to a medial portion of the braid structure.
  • Braid structures can include variations in the number of turns 725 (e.g., loops in the wires 724 at the ends of the braid structure), in the thicknesses of the wires 724, and in the geometries of the braid (e.g., different braid angles). The frame 704 shown in FIG. 7A, for example, is made from a wire 724 a having a thickness of approximately 0.013 inch that forms 10 turns 725 at each end portion of the frame 704. The frame 704 shown in FIG. 7B includes a wire 724 b having a thickness of approximately 0.012 inch that forms 8 turns 725 at each end portion of the frame 704.
  • The frame 704 may be constructed from a variety of resilient metallic materials, polymeric materials (e.g., polyethylenes, polypropylenes, Nylons, PTF Es, and the like), and composites of materials. For example, the wires 724 can be made from biocompatible stainless steels, highly elastic metallic alloys, and bioconmatible shape setting materials (e.g., Nitinol) that exhibit shape memory properties.
  • In various embodiments, the frame 704 can be constrained (e.g., elongated and contracted) to fit within a small sheath of a delivery system (e.g., the proximal sheath 326 and/or the distal sheath 328 of the delivery system 300 of FIGS. 3-6). To facilitate maximal constriction of the frame 704, each longitudinal segment of the braided wire 724 (e.g., between opposing turns 725) can have a substantially equal length. When the frame 704 has varying cross-sectional dimensions or shapes (e.g., a D-shaped superior portion and a circular inferior portion as shown in FIGS. 1A and 1B), the frame 704 can be formed in two stages: (1) the wire 724 can be braided on a dual-diameter mandrel, and (2) a portion of the braided wire 724 can be reshaped on a D-shaped mandrel. This allows the wire 724 to maintain uniform end-to-end distances while conforming to the D-shaped cross section.
  • In various embodiments, the braid pattern of the stent frames 704 can be interrupted to create V-shaped wire turnarounds or medial turns along the length of the braid structure (e.g., midway through the length of the braid structure). Such medial turns can be included in a braid structure that includes multiple wires. For example, in one embodiment, a wire is braided into a first braid pattern (e.g. defining a body of the frame 704) having half of the desired braid density and half of the desired turns at each end portion. A second wire is then braided into the first braid pattern with a set of turnarounds near an end portion of the first braid pattern and a second set of turnarounds between the two end portions (e.g., toward the middle) of the first braid pattern. A third wire can then be braided into the remaining portion of the first braided structure (i.e., the portion of the first braid pattern not already integrated with the second braid pattern) with medial turns proximate the medial turns of the second wire to “fill in” the frame, making the wire density is more uniform along the length of the frame. The apex of individual medial turns may point generally toward one end of the stent frame such that they are flush with the body of the frame.
  • FIGS. 8 and 9 are enlarged views of a distal portion of a stent frame 804 configured in accordance with another embodiment of the present technology. The stent frames 804 include features generally similar to the features of the frames discussed above. However, as shown in FIGS. 8 and 9, the stent frames 804 include medial turns 840 that are bent or otherwise formed to extend or flare radially outward away from the center lumen of the stent frame 804 beyond what would otherwise be defined as the body of the stent frame 804. As discussed in more detail below, the angle θ at which the medial turns 840 project relative to the body of the stent frame 804 may be defined according to desired attributes.
  • In operation, the medial turns 840 can provide a hook or other type of engagement feature that catches on wire diamonds formed by the braid pattern of another stent frame. For example, FIGS. 10 and 11 are side views of a first stent frame 1004 a having medial turns 840 that are disposed substantially concentrically within a second braided stent frame 1004 b. The first stent frame 1004 a can be expanded within the second stent frame 1004 b such that the medial turns extend through the openings of the second stent frame 1004 b. This resists rotation and axial movement of the two stent frames 1004 with respect to one another. In various embodiments, the medial turns 804 are angled away from the body of the first stent frame 1004 a (e.g., not orthogonal to or parallel with the body of the first stent frame 1004 a) such that vascular flow through the stent frames 1004 tends to push the fist stent frame 1004 a in the same general direction in which the medial turns are pointed (e.g., outward from the body of the first stent frame 1004 a). Accordingly, the medial turns 804 can increase the engagement force on the second stent frame 1004 b as a result of the force of vascular flow.
  • In further aspects of the present technology, one or more of the stent frames 1004 can include two sets of medial turns 804 with opposing orientations such that blow flow and other forces in either direction on the stent frames 1004 cause one or both sets of medial turns 804 to embed more deeply into the accompanying stent frame 1004. Such interlocking stent frames 1004 (e.g., with one or more sets of medial turns 804) may be used to create a continuous flow path through different portions of vascular anatomy. For example, a first stent frame 1004 a can he placed within an iliac artery or limb and connected to the second stent frame 1004 b placed above or within an AAA.
  • FIG. 12 is an enlarged side view of a sleeve or cover 1206 for a stent graft configured in accordance with an embodiment of the present technology. In various embodiments, the cover 1206 can he positioned over a stent frame (e.g., as shown in FIGS. 1A and 1B) to define a flow path through one or more stent frames and facilitate the interlocking of stent frames. in the illustrated embodiment, the cover 1206 includes a plurality of circumferential ribs 1242 such that the cover 1206 has an undulating profile that can extend and contract during delivery (e.g., extend to a low-profile, sheathed configuration) and deployment (e.g., expand to a deployed configuration). During expansion, the ribs 1242 of the cover 1206 can mate with ribs 1242 of an opposing cover and interface with vessel walls to enhance the seal and fixation between stent grafts (e.g., the stent grafts 102 of FIGS. 1A and 1B) and between the stent graft and the arterial walls. For example, the apices of the ribs 1242 at the septal wall of a stent graft can interface or mate with the troughs of the corresponding ribs 1242 on a cover of an opposing stent graft. Additionally, the ribs 12 at the outer wall 112 can contact the arterial walls in a manner that at least substantially seals them together.
  • The cover 1206 can be made from a substantially impermeable, biocompatible, and flexible material. For example, the cover 1206 can be made from synthetic polymers, polyurethanes, silicone materials, polyurethane/silicone combinations, rubber materials, woven and non-woven fabrics such as Dacron®, fluoropolymer compositions such as a polytetrafluoroethylene (PTFE) materials, expanded PTFE materials (ePTFE) such as TEFLON®, GORE-TEX®, SOFTFORM®, IMPRA®, and/or other suitable materials. Additionally, in some embodiments, the cover 1206 can be made from a material that is sufficiently porous to permit ingrowth of endothelial cells. Such a porous material can provide more secure anchorages of stent grafts and potentially reduce flow resistance, sheer forces, and leakage of blood around the stent grafts.
  • In various embodiments, the cover 1206 can be attached to as stent frame using a suture material. For example, the zigzagged end portions of the cover 1206 can be sutured to the stent frame. In other embodiments, the suture material may be distributed along the axial length of the stent frame (e.g., following diamond braid pattern) such that the suture material is not distributed in one cross section of the stent graft.
  • Stent Graft Delivery Systems having Stent Covers
  • FIG. 13 is an exploded isometric view of a stent graft delivery system 1300 (“delivery system 1300”) configured in accordance with another embodiment of the present technology, and FIG. 14 is an enlarged exploded, isometric view of a distal portion of the delivery system 1300. Referring to FIGS. 13 and 14 together, the delivery system 1300 can include an outer sheath 1350, a stent graft 1302 (e.g., the stent grafts 1350, 202 and 702 described above with reference to FIGS. 1A-7B) , a distal delivery component 1352, and a stent cover 1354. During assembly of the delivery system 1300, the stent graft 1302 can be held in place at both its proximal and distal end portions by the outer sheath 1350 and the distal delivery component 1354, respectively. The outer sheath 1350 and the distal delivery component 1354 can be referred to collectively as the delivery device. The distal delivery component 1354 can include a distal outer sheath (not shown) configured to cover a distal portion of the stent graft 1302 and/or a central wire 1356 positioned through the stent graft 1302 to navigate the vasculature and/or manipulate the distal outer sheath. In various embodiments, the stent graft 1302 can be only partially sheathed, leaving a portion of the stent graft 1302 (e.g., 3 inches of the stent graft 1302) exposed. The stent cover 1352 can be placed over the stern graft 1302 after it is loaded in the delivery device (see, e.g., FIG. 15). The stent cover 1352 sheathes the stent graft 1302 and a portion of the delivery device during shipping and storage, and assists in introducing the stent graft 1302 through an introducer valve and sheath during clinical use.
  • As further shown in FIGS. 13 and 14, the stent cover 1352 can he a tubular cylinder with a flared proximal end portion 1358. In selected embodiments, the stent cover 1352 can have an inner diameter of approximately 13 Fr and an outer diameter that its into a 14 Fr introducer valve (e.g., approximately 0.220 inch), The stent cover 1352 can have various lengths (e.g, approximately 4 inches) suitable for sheathing a portion or all of the stent graft 1302. The flared proximal end portion 1358 can be approximately 0.260 inch in diameter and 0.25 inch long. In other embodiments, the stent cover 1352 can have larger or smaller inner and/or outer diameters, a differently sized flared proximal end portion 1358, and/or longer or shorter lengths.
  • The stent cover 1352 can be made from high density polyethylene (HDPE), low density polyethylene (LDPE), fluorinated ethylene propylene (FEP), polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), combinations thereof, arid/or other suitable materials. In selected embodiments, the stent cover 1352 can include a liner along the inner diameter made of a material having a low coefficient of friction, such as FEP and PTFE. This can reduce frictional forces as the stent graft 1302 is loaded into the stent cover 1352 (e.g., during manufacturing) and during clinical use of the delivery system 1300.
  • The funnel shape of the flared proximal end portion 1358 can facilitate loading the stent graft 1302 into the stent cover 1352 by gradually compressing fabric (e.g., Dacrone) or other materials on the outer surface of the stent graft 1302 (e.g., a ribbed cover as shown in FIG. 12) as it is inserted into the stent cover 1352. Once positioned over the stent graft 1302 (e.g., as shown in FIG. 15), the stent cover 1352 can maintain the sheathed size of the stent graft 1302 before deployment. In various embodiments, for example, the stent cover 1352 can be positioned over the stent graft 1302 during manufacture to prevent an outer layer of accordion-like folded Dacron®, PTFE, and/or other folded fabric from unfolding or unwrapping, over time. Accordingly, the stent cover 1352 maintains a low profile of the stent graft 1302 such that it can be introduced into a small introducer sheath (e.g., a 10 Fr, 12 Fr, 14 Fr sheath), and therefore allows for percutaneous delivery of the stent graft 1302. By maintaining the low profile of the stent graft 1302, the stent cover 1352 also decreases the forces necessary to deploy the stent graft 1302, thereby increasing control and precision during deployment. Additionally, the stent cover 1352 can be used to house different sizes of stent grafts. This reduces or eliminates the need to increase the size of the introducer sheath for the larger stent grafts, and allows for the use of a 10 Fr, 12 Fr, 14 Fr, etc. introducer valve and sheath even when the stent graft size increases.
  • FIGS. 16-18 are enlarged, isometric views of various stages of the delivery system 1300 as it is being pushed through an introducer valve 1660 in accordance with an embodiment of the present technology. As shown in FIGS. 16 and 17, the delivery system 1300 can be inserted into the introducer valve 1660 and introducer sheath 1662 via the distal delivery component 1354 (FIG. 16), and is pushed through the introducer valve 1660 into the introducer sheath 1662 (FIG. 1). As discussed above, the stent cover 1352 provides sheathing for the stent graft as it is being delivered to the introducer valve 1660 such that the stent graft 1302 maintains a low profile. As shown in FIGS. 17 and 18, the stent cover 1352 can stop inside the introducer valve 1660 (e.g., by abutting an inner surface of the introducer valve 1660) to allow the stent graft 1302, the outer sheath 1.350, and the distal delivery component 1354 to continue through the introducer valve 1660 into the introducer sheath 1662 to the site of the aneurysm. The stent graft 1302 is, therefore, partially exposed (e.g., approximately 3 inches of the stent graft 1302) as it passes through the introducer valve 1660, but the low profile provided by the stent cover 1352 allows it to be introduced into a small introducer sheath (e.g., a 14 Fr introducer sheath, a 10 Fr introducer sheath, etc.).
  • From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but that various modifications may be made without deviating from the disclosure. Certain aspects of the new technology described in the context of particular embodiments may be combined or eliminated in other embodiments. Additionally, while advantages associated with certain embodiments of the new technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology, Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein. Thus, the disclosure is not limited except as by the appended claims.

Claims (13)

1-21. (canceled)
22. A stent graft system, comprising:
a stent graft having a proximal portion and a distal portion;
a proximal sheath covering the proximal portion of the stent graft,
wherein the proximal sheath is configured to be retracted while the proximal portion of the stent graft is simultaneously advanced to deploy the proximal portion of the stent graft, and
wherein the proximal sheath is configured to be retracted and the proximal portion of the stein graft is configured to be advanced at rates corresponding to a ratio of a deployed configuration length of the stent graft to a delivery configuration length of the stent graft;
a distal sheath covering the distal portion of the stent graft; and
a central wire connected to the distal sheath and positioned within the proximal sheath,
wherein
the central wire is configured to advance the distal sheath relative to the stent graft to deploy the distal portion of the stent graft, and
the central wire is configured to retract the distal sheath through an inner lumen formed by the stein graft.
23. The stent graft system of claim 22 wherein the distal portion of the stent graft is configured to be maintained at a constant position while the proximal portion of the stent graft is deployed.
24. The stent graft system of claim 22 wherein the proximal portion of the stent graft is configured to be maintained at a constant position while the distal portion of the stent graft is deployed.
25. The stent graft system of claim 22, further comprising anchoring barbs on the distal portion of the stem graft.
26. The stent graft system of claim 22, further comprising a stent cover having an outer diameter of no greater than 14 Fr.
27. The stent graft system of claim 22 wherein the stent graft comprises a stent frame having a braid pattern forming a body, the braid pattern having medial turns between two ends of the stent frame, and further wherein the medial turns form protrusions extending outwardly from the body of the stent frame.
28. The stent graft system of claim 22, further comprising:
telescoping coaxial tubes for engaging portions of the stent graft, wherein coordinated axial motion of the telescoping tubes during deployment can control the braid angle of the stent graft.
29. The stent graft system of claim 22, further comprising a deployment system having a foreshortening compensation ratio configured to advance the stent graft while simultaneously retracting the sheath relative to the stent graft such that the distal portion of the stent graft is maintained at a single position while transitioning from the sheathed state to the deployed state.
30. A stent graft system, comprising;
a stent graft having a proximal portion and a distal portion;
a distal sheath covering the distal portion of the stent graft,
wherein the distal sheath is configured to be advanced while the distal portion of the stent graft is simultaneously retracted to deploy the distal portion of the stent graft, and
wherein the distal sheath is configured to be retracted and the distal portion of the stent graft is configured to be advanced at rates corresponding to a ratio of a deployed configuration length of the stent graft to a delivery configuration length of the stern graft;
a central wire connected to the distal sheath and positioned within the proximal sheath, wherein the central wire is configured to retract the distal sheath through an inner lumen formed by the stent graft; and
a proximal sheath covering the proximal portion of the stent graft,
31. The stent graft system of claim 30 wherein:
the stent graft has a sheathed configuration and a deployed configuration, wherein the stent graft has a first length in the sheathed configuration and a second length shorter than the first length in the deployed configuration; and
the stent graft system further comprises a deployment system configured to retract the stent graft while simultaneously advancing the sheath relative to the stent graft at rates having a ratio equal to a ratio of the first and second lengths of the stent graft.
32. A delivery system for a braided stent, comprising:
a stent having a frame comprised of braided wire, where the stent comprises a proximal portion and a distal portion;
a proximal sheath covering the proximal portion of the stent,
wherein the proximal sheath is configured to be retracted while the proximal portion of the stent is simultaneously advanced to deploy the proximal portion of the stent, and
wherein the proximal sheath is configured to be retracted and the proximal portion of the stent graft is configured to be advanced at rates corresponding to a ratio of a deployed configuration length of the stent to a delivery configuration length of the stent;
a distal sheath covering the distal portion of the stent; and
a central wire connected to the distal sheath and positioned within the proximal sheath,
wherein
the central wire is configured to advance the distal sheath relative to the stent to deploy the distal portion of the stent, and
the central wire is configured to retract the distal sheath through an inner lumen formed by the stent.
33. The stent delivery system of claim 32, further comprising:
telescoping coaxial tubes for engaging portions of the stent, wherein coordinated axial motion of the telescoping tubes during deployment can control the braid angle of the stent frame.
US14/498,808 2009-05-14 2014-09-26 Stent graft delivery systems and associated methods Abandoned US20150190257A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/498,808 US20150190257A1 (en) 2009-05-14 2014-09-26 Stent graft delivery systems and associated methods

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12/466,044 US20090287145A1 (en) 2008-05-15 2009-05-14 Devices and methods for treatment of abdominal aortic aneurysms
US12/628,131 US20100305686A1 (en) 2008-05-15 2009-11-30 Low-profile modular abdominal aortic aneurysm graft
US26571309P 2009-12-01 2009-12-01
US29358110P 2010-01-08 2010-01-08
US32064610P 2010-04-02 2010-04-02
US38466910P 2010-09-20 2010-09-20
US201161527064P 2011-08-24 2011-08-24
US13/237,822 US8858613B2 (en) 2010-09-20 2011-09-20 Stent graft delivery systems and associated methods
US14/498,808 US20150190257A1 (en) 2009-05-14 2014-09-26 Stent graft delivery systems and associated methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/237,822 Continuation US8858613B2 (en) 2009-05-14 2011-09-20 Stent graft delivery systems and associated methods

Publications (1)

Publication Number Publication Date
US20150190257A1 true US20150190257A1 (en) 2015-07-09

Family

ID=45874134

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/237,822 Active 2031-12-18 US8858613B2 (en) 2009-05-14 2011-09-20 Stent graft delivery systems and associated methods
US14/498,808 Abandoned US20150190257A1 (en) 2009-05-14 2014-09-26 Stent graft delivery systems and associated methods

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/237,822 Active 2031-12-18 US8858613B2 (en) 2009-05-14 2011-09-20 Stent graft delivery systems and associated methods

Country Status (2)

Country Link
US (2) US8858613B2 (en)
WO (1) WO2012040240A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150216684A1 (en) * 2012-08-17 2015-08-06 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
WO2017064484A1 (en) * 2015-10-12 2017-04-20 Lombard Medical Limited Braided medical implant
US20170296324A1 (en) * 2016-04-13 2017-10-19 Medtronic Vascular, Inc. Iliac branch device and method
US11259944B2 (en) 2019-06-27 2022-03-01 Cook Medical Technologies Llc Stent deployment system with unwrapping deployment constraint

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866679B2 (en) 2002-03-12 2005-03-15 Ev3 Inc. Everting stent and stent delivery system
EP2194921B1 (en) 2007-10-04 2018-08-29 TriVascular, Inc. Modular vascular graft for low profile percutaneous delivery
US20100305686A1 (en) * 2008-05-15 2010-12-02 Cragg Andrew H Low-profile modular abdominal aortic aneurysm graft
US20110130825A1 (en) * 2009-12-01 2011-06-02 Altura Medical, Inc. Modular endograft devices and associated systems and methods
WO2012040240A1 (en) * 2010-09-20 2012-03-29 Altura Medical, Inc. Stent graft delivery systems and associated methods
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US20130226278A1 (en) 2012-02-23 2013-08-29 Tyco Healthcare Group Lp Methods and apparatus for luminal stenting
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
CN104470579B (en) 2012-06-06 2018-06-01 洋红医疗有限公司 Artificial kidney valve
US9724222B2 (en) 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
US9486349B2 (en) 2012-08-10 2016-11-08 W. L. Gore & Associates, Inc. Systems and methods of deployment of endoluminal devices
JP6326648B2 (en) 2012-08-10 2018-05-23 アルツラ メディカル インコーポレイテッド Stent delivery system and related method
EP2967361B1 (en) 2013-03-13 2019-12-18 Magenta Medical Ltd. Renal pump
US10583231B2 (en) 2013-03-13 2020-03-10 Magenta Medical Ltd. Blood pump
US9737426B2 (en) 2013-03-15 2017-08-22 Altura Medical, Inc. Endograft device delivery systems and associated methods
US10034784B2 (en) * 2013-04-17 2018-07-31 Gilbert H. L. Tang Heart valve and endovascular graft components and method for delivery
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US10265207B2 (en) 2013-08-27 2019-04-23 Covidien Lp Delivery of medical devices
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
EP3398562B1 (en) 2013-10-28 2022-12-21 Boston Scientific Limited Stent-valve, delivery apparatus and method
US9764113B2 (en) 2013-12-11 2017-09-19 Magenta Medical Ltd Curved catheter
US11291824B2 (en) 2015-05-18 2022-04-05 Magenta Medical Ltd. Blood pump
WO2017015298A1 (en) * 2015-07-19 2017-01-26 Sanford Health Bridging stent graft with interlocking features
GB201517813D0 (en) * 2015-10-08 2015-11-25 Lombard Medical Ltd Braided medical implant
US11039915B2 (en) 2016-09-29 2021-06-22 Magenta Medical Ltd. Blood vessel tube
CA3039285A1 (en) 2016-10-25 2018-05-03 Magenta Medical Ltd. Ventricular assist device
EP3544649B1 (en) 2016-11-23 2023-06-07 Magenta Medical Ltd. Blood pumps
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
US10433993B2 (en) * 2017-01-20 2019-10-08 Medtronic Vascular, Inc. Valve prosthesis having a radially-expandable sleeve integrated thereon for delivery and prevention of paravalvular leakage
US10258492B2 (en) 2017-03-03 2019-04-16 Cook Medical Technologies Llc Prosthesis delivery system with axially collapsible sheath
US10905808B2 (en) 2018-01-10 2021-02-02 Magenta Medical Ltd. Drive cable for use with a blood pump
CN115025386A (en) 2018-01-10 2022-09-09 马真塔医药有限公司 Ventricular assist device
US10893927B2 (en) 2018-03-29 2021-01-19 Magenta Medical Ltd. Inferior vena cava blood-flow implant
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
CN115137966A (en) 2019-01-24 2022-10-04 马真塔医药有限公司 Ventricular assist device
CA3133857A1 (en) 2019-03-20 2020-09-24 inQB8 Medical Technologies, LLC Aortic dissection implant
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems
US12042413B2 (en) 2021-04-07 2024-07-23 Covidien Lp Delivery of medical devices
US12109137B2 (en) 2021-07-30 2024-10-08 Covidien Lp Medical device delivery
US11944558B2 (en) 2021-08-05 2024-04-02 Covidien Lp Medical device delivery devices, systems, and methods
CN115363835B (en) * 2022-10-27 2023-01-31 北京华脉泰科医疗器械股份有限公司 Conveyor for conveying stacked covered stents

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US6702843B1 (en) * 2000-04-12 2004-03-09 Scimed Life Systems, Inc. Stent delivery means with balloon retraction means
US20050131515A1 (en) * 2003-12-16 2005-06-16 Cully Edward H. Removable stent-graft
US7232459B2 (en) * 2002-06-28 2007-06-19 Cook Incorporated Thoracic aortic aneurysm stent graft
US20070233222A1 (en) * 2006-02-21 2007-10-04 Med Institute, Inc. Split sheath deployment system
US8858613B2 (en) * 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods

Family Cites Families (367)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US5104399A (en) 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US6221102B1 (en) 1983-12-09 2001-04-24 Endovascular Technologies, Inc. Intraluminal grafting system
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
SE8803444D0 (en) * 1988-09-28 1988-09-28 Medinvent Sa A DEVICE FOR TRANSLUMINAL IMPLANTATION OR EXTRACTION
US5078726A (en) 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US5578071A (en) 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US6682557B1 (en) 1991-04-11 2004-01-27 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5628783A (en) 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5591172A (en) 1991-06-14 1997-01-07 Ams Medinvent S.A. Transluminal implantation device
ES2109969T3 (en) 1991-10-11 1998-02-01 Angiomed Ag PROCEDURE FOR THE DILATION OF A STENOSIS.
US5693084A (en) 1991-10-25 1997-12-02 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5316023A (en) 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5201757A (en) 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5707376A (en) 1992-08-06 1998-01-13 William Cook Europe A/S Stent introducer and method of use
US5364352A (en) 1993-03-12 1994-11-15 Heart Rhythm Technologies, Inc. Catheter for electrophysiological procedures
WO1994023786A1 (en) 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
US5480423A (en) 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5464449A (en) 1993-07-08 1995-11-07 Thomas J. Fogarty Internal graft prosthesis and delivery system
US5723004A (en) 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5855598A (en) 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5989280A (en) 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5445646A (en) * 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
AU1091095A (en) 1993-11-08 1995-05-29 Harrison M. Lazarus Intraluminal vascular graft and method
US5476505A (en) 1993-11-18 1995-12-19 Advanced Cardiovascular Systems, Inc. Coiled stent and delivery system
DE9319267U1 (en) 1993-12-15 1994-02-24 Günther, Rudolf W., Prof. Dr., 52074 Aachen Aortic endoprosthesis
US5476506A (en) 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6165213A (en) 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5507769A (en) 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
US5415664A (en) 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
US5507731A (en) 1994-05-17 1996-04-16 Cordis Corporation Rapid exchange segmented catheter
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
CA2147547C (en) 1994-08-02 2006-12-19 Peter J. Schmitt Thinly woven flexible graft
US5653743A (en) 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
CA2215027C (en) 1995-03-10 2007-04-10 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
AUPN228395A0 (en) 1995-04-11 1995-05-04 Hart, Vincent G. Artificial arterial-venous graft
US5591228A (en) 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
US5681347A (en) 1995-05-23 1997-10-28 Boston Scientific Corporation Vena cava filter delivery system
EP0773754B1 (en) 1995-05-25 2004-09-01 Medtronic, Inc. Stent assembly
US5702418A (en) 1995-09-12 1997-12-30 Boston Scientific Corporation Stent delivery system
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
GB9522332D0 (en) 1995-11-01 1996-01-03 Biocompatibles Ltd Braided stent
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US6045557A (en) 1995-11-10 2000-04-04 Baxter International Inc. Delivery catheter and method for positioning an intraluminal graft
US20080221668A1 (en) 1995-11-13 2008-09-11 Boston Scientific Corp. Expandable supportive branched endoluminal grafts
US6576009B2 (en) 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5843160A (en) 1996-04-01 1998-12-01 Rhodes; Valentine J. Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen
US6629981B2 (en) 2000-07-06 2003-10-07 Endocare, Inc. Stent delivery system
BE1010183A3 (en) 1996-04-25 1998-02-03 Dereume Jean Pierre Georges Em Luminal endoprosthesis FOR BRANCHING CHANNELS OF A HUMAN OR ANIMAL BODY AND MANUFACTURING METHOD THEREOF.
US6592617B2 (en) 1996-04-30 2003-07-15 Boston Scientific Scimed, Inc. Three-dimensional braided covered stent
US6440165B1 (en) 1996-05-03 2002-08-27 Medinol, Ltd. Bifurcated stent with improved side branch aperture and method of making same
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
NL1003178C2 (en) 1996-05-21 1997-11-25 Cordis Europ Tubular prosthesis made of curable material.
US7238197B2 (en) 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
EP0910309B1 (en) 1996-06-20 2005-02-02 Vascutek Limited Prosthetic repair of body passages
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US6077295A (en) 1996-07-15 2000-06-20 Advanced Cardiovascular Systems, Inc. Self-expanding stent delivery system
US5830217A (en) 1996-08-09 1998-11-03 Thomas J. Fogarty Soluble fixation device and method for stent delivery catheters
US6325819B1 (en) 1996-08-19 2001-12-04 Cook Incorporated Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm
US5968068A (en) 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
US5968052A (en) 1996-11-27 1999-10-19 Scimed Life Systems Inc. Pull back stent delivery system with pistol grip retraction handle
US5897587A (en) 1996-12-03 1999-04-27 Atrium Medical Corporation Multi-stage prosthesis
US5776142A (en) 1996-12-19 1998-07-07 Medtronic, Inc. Controllable stent delivery system and method
US6015431A (en) 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US6090128A (en) 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
US6951572B1 (en) 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
US5948483A (en) 1997-03-25 1999-09-07 The Board Of Trustees Of The University Of Illinois Method and apparatus for producing thin film and nanoparticle deposits
GR970100134A (en) 1997-04-10 1998-12-31 Bifurcated inravascular implant for the intravascular treatment of aneurysms of the abdominal aorta and implanting technique
GB9710366D0 (en) 1997-05-20 1997-07-16 Biocompatibles Ltd Stent deployment device
AUPO700897A0 (en) 1997-05-26 1997-06-19 William A Cook Australia Pty Ltd A method and means of deploying a graft
US6168616B1 (en) 1997-06-02 2001-01-02 Global Vascular Concepts Manually expandable stent
US6007575A (en) 1997-06-06 1999-12-28 Samuels; Shaun Laurence Wilkie Inflatable intraluminal stent and method for affixing same within the human body
US5904713A (en) 1997-07-14 1999-05-18 Datascope Investment Corp. Invertible bifurcated stent/graft and method of deployment
US5906619A (en) 1997-07-24 1999-05-25 Medtronic, Inc. Disposable delivery device for endoluminal prostheses
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6306164B1 (en) 1997-09-05 2001-10-23 C. R. Bard, Inc. Short body endoprosthesis
US5984955A (en) 1997-09-11 1999-11-16 Wisselink; Willem System and method for endoluminal grafting of bifurcated or branched vessels
US6183444B1 (en) 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US6179809B1 (en) 1997-09-24 2001-01-30 Eclipse Surgical Technologies, Inc. Drug delivery catheter with tip alignment
US6554794B1 (en) 1997-09-24 2003-04-29 Richard L. Mueller Non-deforming deflectable multi-lumen catheter
EP1018949B1 (en) 1997-10-02 2005-08-24 Boston Scientific Limited Device for delivering fiber material into a body
WO1999026559A1 (en) 1997-11-25 1999-06-03 Triad Vascular Systems, Inc. Layered endovascular graft
US6171277B1 (en) 1997-12-01 2001-01-09 Cordis Webster, Inc. Bi-directional control handle for steerable catheter
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
FR2775182B1 (en) 1998-02-25 2000-07-28 Legona Anstalt DEVICE FORMING INTRACORPOREAL ENDOLUMINAL ANDOPROTHESIS, IN PARTICULAR AORTIC ABDOMINAL
US6077296A (en) 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US6019778A (en) 1998-03-13 2000-02-01 Cordis Corporation Delivery apparatus for a self-expanding stent
US6129756A (en) 1998-03-16 2000-10-10 Teramed, Inc. Biluminal endovascular graft system
US6224609B1 (en) 1998-03-16 2001-05-01 Teramed Inc. Bifurcated prosthetic graft
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6887268B2 (en) 1998-03-30 2005-05-03 Cordis Corporation Extension prosthesis for an arterial repair
US6520983B1 (en) 1998-03-31 2003-02-18 Scimed Life Systems, Inc. Stent delivery system
US6524336B1 (en) 1998-04-09 2003-02-25 Cook Incorporated Endovascular graft
US6217609B1 (en) 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US6120522A (en) 1998-08-27 2000-09-19 Scimed Life Systems, Inc. Self-expanding stent delivery catheter
WO2000018330A1 (en) 1998-09-30 2000-04-06 Impra, Inc. Delivery mechanism for implantable stent
US6203550B1 (en) 1998-09-30 2001-03-20 Medtronic, Inc. Disposable delivery device for endoluminal prostheses
US6273909B1 (en) 1998-10-05 2001-08-14 Teramed Inc. Endovascular graft system
US6214036B1 (en) 1998-11-09 2001-04-10 Cordis Corporation Stent which is easily recaptured and repositioned within the body
US6371963B1 (en) 1998-11-17 2002-04-16 Scimed Life Systems, Inc. Device for controlled endoscopic penetration of injection needle
US6197049B1 (en) 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
AU768071B2 (en) 1999-01-22 2003-12-04 W.L. Gore & Associates, Inc. Low profile stent and graft combination
US6517571B1 (en) 1999-01-22 2003-02-11 Gore Enterprise Holdings, Inc. Vascular graft with improved flow surfaces
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
BR0007932A (en) 1999-02-01 2002-07-02 Univ Texas Bifurcated and trifurcated braided stents and methods for their manufacture
US6162246A (en) 1999-02-16 2000-12-19 Barone; Hector Daniel Aortic graft and method of treating abdominal aortic aneurysms
US6231597B1 (en) 1999-02-16 2001-05-15 Mark E. Deem Apparatus and methods for selectively stenting a portion of a vessel wall
US6200339B1 (en) 1999-02-23 2001-03-13 Datascope Investment Corp. Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis
WO2000049973A2 (en) 1999-02-26 2000-08-31 Vascular Architects, Inc. Coiled stent and catheter assembly
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6743247B1 (en) 1999-04-01 2004-06-01 Scion Cardio-Vascular, Inc. Locking frame, filter and deployment system
US6162237A (en) 1999-04-19 2000-12-19 Chan; Winston Kam Yew Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury
US6926724B1 (en) 1999-05-04 2005-08-09 City Of Hope Visceral anastomotic device and method of using same
US6146415A (en) 1999-05-07 2000-11-14 Advanced Cardiovascular Systems, Inc. Stent delivery system
US6468260B1 (en) 1999-05-07 2002-10-22 Biosense Webster, Inc. Single gear drive bidirectional control handle for steerable catheter
US6585756B1 (en) 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
US6398802B1 (en) * 1999-06-21 2002-06-04 Scimed Life Systems, Inc. Low profile delivery system for stent and graft deployment
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6652570B2 (en) 1999-07-02 2003-11-25 Scimed Life Systems, Inc. Composite vascular graft
EP1196114A1 (en) 1999-07-16 2002-04-17 Sunnanväder, Lars A device for therapeutic treatment of a blood vessel
US6230476B1 (en) 1999-09-02 2001-05-15 Gary W. Clem, Inc. Row crop gathering belt for combine heads
US6183481B1 (en) 1999-09-22 2001-02-06 Endomed Inc. Delivery system for self-expanding stents and grafts
US6344056B1 (en) 1999-12-29 2002-02-05 Edwards Lifesciences Corp. Vascular grafts for bridging a vessel side branch
US6270525B1 (en) 1999-09-23 2001-08-07 Cordis Corporation Precursor stent gasket for receiving bilateral grafts having controlled contralateral guidewire access
US6344052B1 (en) 1999-09-27 2002-02-05 World Medical Manufacturing Corporation Tubular graft with monofilament fibers
US6849087B1 (en) 1999-10-06 2005-02-01 Timothy A. M. Chuter Device and method for staged implantation of a graft for vascular repair
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US6652567B1 (en) 1999-11-18 2003-11-25 David H. Deaton Fenestrated endovascular graft
US6280466B1 (en) 1999-12-03 2001-08-28 Teramed Inc. Endovascular graft system
GB0001102D0 (en) 2000-01-19 2000-03-08 Sulzer Vascutek Ltd Prosthesis
US6398807B1 (en) 2000-01-31 2002-06-04 Scimed Life Systems, Inc. Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
US6325822B1 (en) 2000-01-31 2001-12-04 Scimed Life Systems, Inc. Braided stent having tapered filaments
US6602280B2 (en) 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US6344044B1 (en) 2000-02-11 2002-02-05 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
US6808534B1 (en) 2000-02-16 2004-10-26 Endovascular Technologies, Inc. Collapsible jacket guard
US6814752B1 (en) 2000-03-03 2004-11-09 Endovascular Technologies, Inc. Modular grafting system and method
CA2400072C (en) 2000-03-14 2010-01-19 Cook Incorporated Endovascular stent graft
US6942691B1 (en) 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
US6361556B1 (en) 2000-04-27 2002-03-26 Endovascular Tech Inc System and method for endovascular aneurysm repair in conjuction with vascular stabilization
US7226474B2 (en) 2000-05-01 2007-06-05 Endovascular Technologies, Inc. Modular graft component junctions
US7135037B1 (en) 2000-05-01 2006-11-14 Endovascular Technologies, Inc. System and method for forming a junction between elements of a modular endovascular prosthesis
US6572643B1 (en) 2000-07-19 2003-06-03 Vascular Architects, Inc. Endoprosthesis delivery catheter assembly and method
US6808533B1 (en) 2000-07-28 2004-10-26 Atrium Medical Corporation Covered stent and method of covering a stent
US7118592B1 (en) 2000-09-12 2006-10-10 Advanced Cardiovascular Systems, Inc. Covered stent assembly for reduced-shortening during stent expansion
US6730119B1 (en) 2000-10-06 2004-05-04 Board Of Regents Of The University Of Texas System Percutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity
US7229472B2 (en) 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US6942692B2 (en) 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
US7314483B2 (en) 2000-11-16 2008-01-01 Cordis Corp. Stent graft with branch leg
US6843802B1 (en) 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
US7267685B2 (en) 2000-11-16 2007-09-11 Cordis Corporation Bilateral extension prosthesis and method of delivery
US6645242B1 (en) 2000-12-11 2003-11-11 Stephen F. Quinn Bifurcated side-access intravascular stent graft
US20020169497A1 (en) 2001-01-02 2002-11-14 Petra Wholey Endovascular stent system and method of providing aneurysm embolization
US6602225B2 (en) 2001-02-28 2003-08-05 Scimed Life Systems, Inc Substantially circular catheter assembly
WO2002070167A1 (en) 2001-03-05 2002-09-12 Idev Technologies, Inc. Methods for securing strands of woven medical devices
US20020143387A1 (en) 2001-03-27 2002-10-03 Soetikno Roy M. Stent repositioning and removal
ATE272369T1 (en) 2001-03-27 2004-08-15 Cook William Europ VESSEL TRANSPLANT FOR THE AORTA
KR20030094304A (en) * 2001-03-28 2003-12-11 쿡 인코포레이티드 Modular stent graft assembly and use thereof
US20040215322A1 (en) 2001-07-06 2004-10-28 Andrew Kerr Stent/graft assembly
US6761733B2 (en) 2001-04-11 2004-07-13 Trivascular, Inc. Delivery system and method for bifurcated endovascular graft
US20040138734A1 (en) 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US6733521B2 (en) 2001-04-11 2004-05-11 Trivascular, Inc. Delivery system and method for endovascular graft
US7175651B2 (en) 2001-07-06 2007-02-13 Andrew Kerr Stent/graft assembly
US20040073288A1 (en) 2001-07-06 2004-04-15 Andrew Kerr Stent/graft assembly
US20050021123A1 (en) 2001-04-30 2005-01-27 Jurgen Dorn Variable speed self-expanding stent delivery system and luer locking connector
US7828833B2 (en) 2001-06-11 2010-11-09 Boston Scientific Scimed, Inc. Composite ePTFE/textile prosthesis
US6716239B2 (en) 2001-07-03 2004-04-06 Scimed Life Systems, Inc. ePTFE graft with axial elongation properties
WO2003003944A2 (en) 2001-07-06 2003-01-16 Angiomed Gmbh & Co. Medizintechnik Kg Delivery system having a rapid pusher assembly for self-expanding stent, and stent exchange configuration
US20030014075A1 (en) 2001-07-16 2003-01-16 Microvention, Inc. Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation
US6755854B2 (en) 2001-07-31 2004-06-29 Advanced Cardiovascular Systems, Inc. Control device and mechanism for deploying a self-expanding medical device
GB0123633D0 (en) 2001-10-02 2001-11-21 Angiomed Ag Stent delivery system
US6939352B2 (en) 2001-10-12 2005-09-06 Cordis Corporation Handle deployment mechanism for medical device and method
US6866669B2 (en) 2001-10-12 2005-03-15 Cordis Corporation Locking handle deployment mechanism for medical device and method
US20030074055A1 (en) 2001-10-17 2003-04-17 Haverkost Patrick A. Method and system for fixation of endoluminal devices
AUPR847301A0 (en) 2001-10-26 2001-11-15 Cook Incorporated Endoluminal prostheses for curved lumens
US7823267B2 (en) 2001-11-28 2010-11-02 Aptus Endosystems, Inc. Devices, systems, and methods for prosthesis delivery and implantation, including the use of a fastener tool
US6929661B2 (en) 2001-11-28 2005-08-16 Aptus Endosystems, Inc. Multi-lumen prosthesis systems and methods
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7014653B2 (en) 2001-12-20 2006-03-21 Cleveland Clinic Foundation Furcated endovascular prosthesis
US6913594B2 (en) 2001-12-31 2005-07-05 Biosense Webster, Inc. Dual-function catheter handle
US20030130720A1 (en) 2002-01-08 2003-07-10 Depalma Donald F. Modular aneurysm repair system
US20030130725A1 (en) 2002-01-08 2003-07-10 Depalma Donald F. Sealing prosthesis
US7326237B2 (en) 2002-01-08 2008-02-05 Cordis Corporation Supra-renal anchoring prosthesis
GB0203177D0 (en) 2002-02-11 2002-03-27 Anson Medical Ltd An improved control mechanism for medical catheters
WO2003071929A2 (en) 2002-02-26 2003-09-04 Endovascular Technologies, Inc. Endovascular grafting device
US7708771B2 (en) 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
US7000649B2 (en) 2002-03-20 2006-02-21 Terumo Kabushiki Kaisha Woven tubing for stent type blood vascular prosthesis and stent type blood vascular prosthesis using the tubing
US7063721B2 (en) 2002-03-20 2006-06-20 Terumo Kabushiki Kaisha Woven tubing for stent type blood vascular prosthesis and stent type blood vascular prosthesis using the tubing
AU2003224769B2 (en) 2002-03-25 2007-10-18 Cook Incorporated Branched vessel prothesis
US7052511B2 (en) * 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Delivery system and method for deployment of foreshortening endoluminal devices
US6911039B2 (en) 2002-04-23 2005-06-28 Medtronic Vascular, Inc. Integrated mechanical handle with quick slide mechanism
US7105016B2 (en) 2002-04-23 2006-09-12 Medtronic Vascular, Inc. Integrated mechanical handle with quick slide mechanism
US7131991B2 (en) 2002-04-24 2006-11-07 Medtronic Vascular, Inc. Endoluminal prosthetic assembly and extension method
US6830575B2 (en) 2002-05-08 2004-12-14 Scimed Life Systems, Inc. Method and device for providing full protection to a stent
US20040117003A1 (en) 2002-05-28 2004-06-17 The Cleveland Clinic Foundation Minimally invasive treatment system for aortic aneurysms
US7264632B2 (en) 2002-06-07 2007-09-04 Medtronic Vascular, Inc. Controlled deployment delivery system
US6858038B2 (en) 2002-06-21 2005-02-22 Richard R. Heuser Stent system
US7314484B2 (en) 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US11890181B2 (en) 2002-07-22 2024-02-06 Tmt Systems, Inc. Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
US20040019375A1 (en) 2002-07-26 2004-01-29 Scimed Life Systems, Inc. Sectional crimped graft
US6984243B2 (en) 2002-07-30 2006-01-10 Cordis Corporation Abrasion resistant vascular graft
US7550004B2 (en) 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
EP1545396B1 (en) 2002-08-23 2008-12-17 William A. Cook Australia Pty. Ltd. Composite prosthesis
US7264631B2 (en) 2002-09-16 2007-09-04 Scimed Life Systems, Inc. Devices and methods for AAA management
US20040059406A1 (en) 2002-09-20 2004-03-25 Cully Edward H. Medical device amenable to fenestration
DE60325999D1 (en) 2002-12-04 2009-03-12 Cook Inc DEVICE FOR TREATING THE THORAX AORTA
US6849084B2 (en) 2002-12-31 2005-02-01 Intek Technology L.L.C. Stent delivery system
US7763062B2 (en) 2003-01-21 2010-07-27 Boston Scientific Scimed, Inc. Method and system for delivering and implanting a graft
ITTO20030037A1 (en) 2003-01-24 2004-07-25 Sorin Biomedica Cardio S P A Ora S Orin Biomedica CATHETER DRIVE DEVICE.
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7169118B2 (en) 2003-02-26 2007-01-30 Scimed Life Systems, Inc. Elongate medical device with distal cap
US7220274B1 (en) 2003-03-21 2007-05-22 Quinn Stephen F Intravascular stent grafts and methods for deploying the same
WO2004093746A1 (en) 2003-03-26 2004-11-04 The Foundry Inc. Devices and methods for treatment of abdominal aortic aneurysm
US6984244B2 (en) 2003-03-27 2006-01-10 Endovascular Technologies, Inc. Delivery system for endoluminal implant
US20070032852A1 (en) 2003-04-25 2007-02-08 Medtronic Vascular, Inc. Methods and Apparatus for Treatment of Aneurysms Adjacent to Branch Arteries
US20050033416A1 (en) 2003-05-02 2005-02-10 Jacques Seguin Vascular graft and deployment system
US20040230289A1 (en) 2003-05-15 2004-11-18 Scimed Life Systems, Inc. Sealable attachment of endovascular stent to graft
US7235093B2 (en) 2003-05-20 2007-06-26 Boston Scientific Scimed, Inc. Mechanism to improve stent securement
EP1635736A2 (en) 2003-06-05 2006-03-22 FlowMedica, Inc. Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens
US8721710B2 (en) 2003-08-11 2014-05-13 Hdh Medical Ltd. Anastomosis system and method
US7628806B2 (en) 2003-08-20 2009-12-08 Boston Scientific Scimed, Inc. Stent with improved resistance to migration
EP1670390B1 (en) 2003-09-02 2008-12-24 Abbott Laboratories Delivery system for a medical device
US7993384B2 (en) 2003-09-12 2011-08-09 Abbott Cardiovascular Systems Inc. Delivery system for medical devices
US7758625B2 (en) * 2003-09-12 2010-07-20 Abbott Vascular Solutions Inc. Delivery system for medical devices
CN1272053C (en) 2003-09-23 2006-08-30 邢文照 Chinese medicine for treating tuberculosis and its prepn and use
WO2005032340A2 (en) 2003-09-29 2005-04-14 Secant Medical, Llc Integral support stent graft assembly
US20050085894A1 (en) 2003-10-16 2005-04-21 Kershner James R. High strength and lubricious materials for vascular grafts
US7144421B2 (en) 2003-11-06 2006-12-05 Carpenter Judith T Endovascular prosthesis, system and method
US20050171597A1 (en) 2003-11-08 2005-08-04 Boatman Scott E. Helical stent for branched vessel prosthesis
US7655040B2 (en) 2003-11-12 2010-02-02 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
US7575591B2 (en) 2003-12-01 2009-08-18 Cordis Corporation Prosthesis graft with Z pleating
US20050137677A1 (en) 2003-12-17 2005-06-23 Rush Scott L. Endovascular graft with differentiable porosity along its length
US20050154441A1 (en) * 2004-01-14 2005-07-14 Cook Incorporated Introducer
EP1719538B1 (en) 2004-02-27 2015-09-30 Sumitomo Electric Industries, Ltd. Composite structure and process for producing the same
EP1753367A4 (en) 2004-03-11 2011-10-12 Trivascular Inc Modular endovascular graft
CA2562463C (en) 2004-04-12 2014-03-25 Cook Incorporated Stent graft repair device
US7682381B2 (en) 2004-04-23 2010-03-23 Boston Scientific Scimed, Inc. Composite medical textile material and implantable devices made therefrom
US7766960B2 (en) 2004-04-30 2010-08-03 Novostent Corporation Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use
WO2005112823A1 (en) 2004-05-04 2005-12-01 The Board Of Regents Of The University Of Texas System Percutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity
US20050273154A1 (en) 2004-06-08 2005-12-08 Colone William M Bifurcated stent graft and apparatus for making same
US7318835B2 (en) 2004-07-20 2008-01-15 Medtronic Vascular, Inc. Endoluminal prosthesis having expandable graft sections
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
DE602005018220D1 (en) 2004-07-28 2010-01-21 Cordis Corp SUPPORT STRUCTURE WITH FLAT PROFILE FOR BAY CHAIN ENERYSM
US20060030921A1 (en) 2004-08-03 2006-02-09 Medtronic Vascular, Inc. Intravascular securement device
US7695506B2 (en) 2004-09-21 2010-04-13 Boston Scientific Scimed, Inc. Atraumatic connections for multi-component stents
US20070179600A1 (en) 2004-10-04 2007-08-02 Gil Vardi Stent graft including expandable cuff
US20060074481A1 (en) 2004-10-04 2006-04-06 Gil Vardi Graft including expandable cuff
US7344560B2 (en) 2004-10-08 2008-03-18 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20060085057A1 (en) 2004-10-14 2006-04-20 Cardiomind Delivery guide member based stent anti-jumping technologies
EP1807022A2 (en) 2004-11-03 2007-07-18 Jacques Seguin Vascular graft and deployment system
US20080108969A1 (en) 2005-11-28 2008-05-08 Andrew Kerr Dialysis Catheter
US8858495B2 (en) 2004-12-28 2014-10-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Five degree of freedom ultrasound catheter and catheter control handle
US7691095B2 (en) 2004-12-28 2010-04-06 St. Jude Medical, Atrial Fibrillation Division, Inc. Bi-directional steerable catheter control handle
US7588596B2 (en) 2004-12-29 2009-09-15 Scimed Life Systems, Inc. Endoluminal prosthesis adapted to resist migration and method of deploying the same
US20060155366A1 (en) 2005-01-10 2006-07-13 Laduca Robert Apparatus and method for deploying an implantable device within the body
US8287583B2 (en) 2005-01-10 2012-10-16 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US7578838B2 (en) 2005-01-12 2009-08-25 Cook Incorporated Delivery system with helical shaft
US7306623B2 (en) 2005-01-13 2007-12-11 Medtronic Vascular, Inc. Branch vessel graft design and deployment method
WO2006079006A2 (en) 2005-01-21 2006-07-27 Gen 4, Llc Modular stent graft employing bifurcated graft and leg locking stent elements
US7918880B2 (en) 2005-02-16 2011-04-05 Boston Scientific Scimed, Inc. Self-expanding stent and delivery system
US20060224232A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Hybrid modular endovascular graft
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US20060233990A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US8357190B2 (en) 2005-05-10 2013-01-22 Cook Medical Technologies Llc Laparoscopic vascular access
EP1885287A2 (en) 2005-05-13 2008-02-13 Alveolus Inc. Intravascular implant delivery device with anchoring features and associated method
CN2817768Y (en) 2005-05-24 2006-09-20 微创医疗器械(上海)有限公司 Tectorium stand and host cage section thereof
GB0512319D0 (en) 2005-06-16 2005-07-27 Angiomed Ag Catheter device variable pusher
US9149378B2 (en) * 2005-08-02 2015-10-06 Reva Medical, Inc. Axially nested slide and lock expandable device
WO2007022526A1 (en) 2005-08-18 2007-02-22 William A. Cook Australia Pty. Ltd. Assembly of stent grafts
US20070055341A1 (en) 2005-08-26 2007-03-08 Vascular And Endovascular Surgical Technologies, Inc. Endograft
US8911491B2 (en) 2005-09-02 2014-12-16 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent branch arteries including branch artery flow lumen alignment
US8551153B2 (en) 2005-12-20 2013-10-08 Cordis Corporation Prosthesis comprising a coiled stent and method of use thereof
US20070150041A1 (en) 2005-12-22 2007-06-28 Nellix, Inc. Methods and systems for aneurysm treatment using filling structures
US8167892B2 (en) 2005-12-29 2012-05-01 Cordis Corporation Adjustable and detached stent deployment device
US20070156229A1 (en) 2005-12-30 2007-07-05 Park Jin S "D"-shape stent for treatment of abdominal aortic aneurysm
US20070156224A1 (en) 2006-01-04 2007-07-05 Iulian Cioanta Handle system for deploying a prosthetic implant
US20070162109A1 (en) 2006-01-11 2007-07-12 Luis Davila Intraluminal stent graft
US8900287B2 (en) 2006-01-13 2014-12-02 Aga Medical Corporation Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm
US9375215B2 (en) 2006-01-20 2016-06-28 W. L. Gore & Associates, Inc. Device for rapid repair of body conduits
US8083792B2 (en) 2006-01-24 2011-12-27 Cordis Corporation Percutaneous endoprosthesis using suprarenal fixation and barbed anchors
US20080114435A1 (en) 2006-03-07 2008-05-15 Med Institute, Inc. Flexible delivery system
US8197536B2 (en) 2006-03-10 2012-06-12 Cordis Corporation Method for placing a medical device at a bifurcated conduit
US20070225797A1 (en) 2006-03-24 2007-09-27 Medtronic Vascular, Inc. Prosthesis With Adjustable Opening for Side Branch Access
US7481836B2 (en) 2006-03-30 2009-01-27 Medtronic Vascular, Inc. Prosthesis with coupling zone and methods
US9757260B2 (en) 2006-03-30 2017-09-12 Medtronic Vascular, Inc. Prosthesis with guide lumen
US20070244547A1 (en) 2006-04-18 2007-10-18 Medtronic Vascular, Inc., A Delaware Corporation Device and Method for Controlling the Positioning of a Stent Graft Fenestration
US7678141B2 (en) 2006-04-18 2010-03-16 Medtronic Vascular, Inc. Stent graft having a flexible, articulable, and axially compressible branch graft
WO2007127352A1 (en) 2006-04-27 2007-11-08 William A. Cook Australia Pty. Ltd. Handle for a deployment device
US7615044B2 (en) 2006-05-03 2009-11-10 Greatbatch Ltd. Deflectable sheath handle assembly and method therefor
US20100292771A1 (en) 2009-05-18 2010-11-18 Syncardia Systems, Inc Endovascular stent graft system and guide system
WO2007146021A2 (en) 2006-06-06 2007-12-21 Cook Incorporated Stent with a crush-resistant zone
KR20090025331A (en) 2006-06-20 2009-03-10 가부시키가이샤 엔티티 도코모 Radio communication device and method used in mobile communication system
US8202310B2 (en) 2006-07-14 2012-06-19 Cordis Corporation AAA repair device with aneurysm sac access port
AU2007284361B2 (en) 2006-08-18 2012-06-14 Cook Incorporated Stent graft extension
ES2382364T3 (en) 2006-09-28 2012-06-07 St George Medical Inc Thoracic aortic aneurysm repair device.
MX344492B (en) 2006-10-22 2016-12-16 Idev Tech Inc * Devices and methods for stent advancement.
MX2009004291A (en) 2006-10-22 2009-09-07 Idev Technologies Inc Methods for securing strand ends and the resulting devices.
US20080114444A1 (en) 2006-11-09 2008-05-15 Chun Ho Yu Modular stent graft and delivery system
US8052732B2 (en) 2006-11-14 2011-11-08 Medtronic Vascular, Inc. Delivery system for stent-graft with anchoring pins
KR100801122B1 (en) 2006-11-17 2008-02-05 (주)블루버드 소프트 Mobile terminal
US9044311B2 (en) 2006-11-30 2015-06-02 Cook Medical Technologies Llc Aortic graft device
US8216298B2 (en) 2007-01-05 2012-07-10 Medtronic Vascular, Inc. Branch vessel graft method and delivery system
WO2008091409A1 (en) 2007-01-25 2008-07-31 Boston Scientific Limited Endoscope with preloaded or preloadable stent
US8034093B2 (en) 2007-01-31 2011-10-11 William A. Cook Australia Pty. Ltd. Endoscopic delivery device
JP5662683B2 (en) 2007-02-09 2015-02-04 タヘリ ラドュカ エルエルシー Apparatus and method for deploying an implantable device in a body
US20080208325A1 (en) 2007-02-27 2008-08-28 Boston Scientific Scimed, Inc. Medical articles for long term implantation
WO2008124728A1 (en) 2007-04-09 2008-10-16 Ev3 Peripheral, Inc. Stretchable stent and delivery system
US8715336B2 (en) 2007-04-19 2014-05-06 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
US8048147B2 (en) 2007-06-27 2011-11-01 Aga Medical Corporation Branched stent/graft and method of fabrication
US8372131B2 (en) 2007-07-16 2013-02-12 Power Ten , LLC Surgical site access system and deployment device for same
US20090043376A1 (en) 2007-08-08 2009-02-12 Hamer Rochelle M Endoluminal Prosthetic Conduit Systems and Method of Coupling
EP2194921B1 (en) 2007-10-04 2018-08-29 TriVascular, Inc. Modular vascular graft for low profile percutaneous delivery
US9414842B2 (en) 2007-10-12 2016-08-16 St. Jude Medical, Cardiology Division, Inc. Multi-component vascular device
US9107741B2 (en) 2007-11-01 2015-08-18 Cook Medical Technologies Llc Flexible stent graft
US20090164001A1 (en) 2007-12-21 2009-06-25 Biggs David P Socket For Fenestrated Tubular Prosthesis
US8021413B2 (en) 2007-12-27 2011-09-20 Cook Medical Technologies Llc Low profile medical device
US20090171451A1 (en) 2007-12-27 2009-07-02 Cook Incorporated Implantable device having composite weave
US8926688B2 (en) 2008-01-11 2015-01-06 W. L. Gore & Assoc. Inc. Stent having adjacent elements connected by flexible webs
CA3010828A1 (en) 2008-01-17 2009-07-23 Boston Scientific Scimed, Inc. Stent with anti-migration feature
US8163004B2 (en) 2008-02-18 2012-04-24 Aga Medical Corporation Stent graft for reinforcement of vascular abnormalities and associated method
US20090228020A1 (en) 2008-03-06 2009-09-10 Hansen Medical, Inc. In-situ graft fenestration
US7655037B2 (en) 2008-04-17 2010-02-02 Cordis Corporation Combination barb restraint and stent attachment deployment mechanism
EP2278939B1 (en) 2008-04-25 2021-04-14 Endologix LLC Stent graft delivery system
US20100305686A1 (en) 2008-05-15 2010-12-02 Cragg Andrew H Low-profile modular abdominal aortic aneurysm graft
US20090287145A1 (en) 2008-05-15 2009-11-19 Altura Interventional, Inc. Devices and methods for treatment of abdominal aortic aneurysms
AU2009262832A1 (en) 2008-06-04 2009-12-30 Nellix, Inc. Docking apparatus and methods of use
US8114147B2 (en) 2008-06-16 2012-02-14 Boston Scientific Scimed, Inc. Continuous double layered stent for migration resistance
EP3636220A3 (en) 2008-06-30 2020-07-22 Bolton Medical Inc. Abdominal aortic aneurysms systems
US20100030321A1 (en) 2008-07-29 2010-02-04 Aga Medical Corporation Medical device including corrugated braid and associated method
DE102008048533A1 (en) 2008-09-16 2010-03-25 Jotec Gmbh Delivery system for discontinuing catheter-based stent devices
US9375307B2 (en) 2008-09-17 2016-06-28 Cook Medical Technologies Llc Graft fabric crimping pattern
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US9597214B2 (en) 2008-10-10 2017-03-21 Kevin Heraty Medical device
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US9427302B2 (en) 2009-04-09 2016-08-30 Medtronic Vascular, Inc. Stent having a C-shaped body section for use in a bifurcation
WO2010121145A1 (en) 2009-04-16 2010-10-21 Cook Incorporated Introducer assembly
EP2448519A1 (en) 2009-07-01 2012-05-09 Correx, INC. Method and apparatus for effecting an aortic valve bypass, including the provision and use of a t-stent for effecting a distal anastomosis for the same
AU2010308380B2 (en) 2009-10-20 2013-04-04 Cook Medical Technologies Llc Rotational controlled deployment device
US20110130825A1 (en) 2009-12-01 2011-06-02 Altura Medical, Inc. Modular endograft devices and associated systems and methods
US20110213450A1 (en) 2010-03-01 2011-09-01 Koven Technology Canada, Inc. Medical device delivery system
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
JP2013532029A (en) 2010-06-18 2013-08-15 クック メディカル テクノロジーズ エルエルシー Bifurcated stent insertion system
US9039750B2 (en) 2010-12-16 2015-05-26 Cook Medical Technologies Llc Handle control system for a stent delivery system
US20120185031A1 (en) 2011-01-19 2012-07-19 Michael Ryan Rotary and linear handle mechanism for constrained stent delivery system
US9486348B2 (en) 2011-02-01 2016-11-08 S. Jude Medical, Cardiology Division, Inc. Vascular delivery system and method
WO2012118638A1 (en) 2011-02-28 2012-09-07 Cook Medical Technologies Llc Short throw centered handle for stent delivery system
AU2011202175B1 (en) 2011-05-11 2011-07-28 Cook Medical Technologies Llc Rotation operated delivery device
AU2012209013B2 (en) 2011-08-02 2013-11-14 Cook Medical Technologies Llc Delivery device having a variable diameter introducer sheath
US20130123898A1 (en) 2011-11-15 2013-05-16 Boston Scientific Scimed, Inc. Medical device with one or more sheathing transition members

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US6702843B1 (en) * 2000-04-12 2004-03-09 Scimed Life Systems, Inc. Stent delivery means with balloon retraction means
US7232459B2 (en) * 2002-06-28 2007-06-19 Cook Incorporated Thoracic aortic aneurysm stent graft
US20050131515A1 (en) * 2003-12-16 2005-06-16 Cully Edward H. Removable stent-graft
US20070233222A1 (en) * 2006-02-21 2007-10-04 Med Institute, Inc. Split sheath deployment system
US8858613B2 (en) * 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150216684A1 (en) * 2012-08-17 2015-08-06 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
US9763812B2 (en) * 2012-08-17 2017-09-19 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
WO2017064484A1 (en) * 2015-10-12 2017-04-20 Lombard Medical Limited Braided medical implant
US20170296324A1 (en) * 2016-04-13 2017-10-19 Medtronic Vascular, Inc. Iliac branch device and method
US9987122B2 (en) * 2016-04-13 2018-06-05 Medtronic Vascular, Inc. Iliac branch device and method
US11259944B2 (en) 2019-06-27 2022-03-01 Cook Medical Technologies Llc Stent deployment system with unwrapping deployment constraint

Also Published As

Publication number Publication date
WO2012040240A1 (en) 2012-03-29
US20120130469A1 (en) 2012-05-24
US8858613B2 (en) 2014-10-14

Similar Documents

Publication Publication Date Title
US8858613B2 (en) Stent graft delivery systems and associated methods
US7232459B2 (en) Thoracic aortic aneurysm stent graft
AU2012202507B2 (en) Steerable iliac branch device
US9198787B2 (en) Conformable prosthesis delivery system and method for deployment thereof
US6551350B1 (en) Kink resistant bifurcated prosthesis
US9572652B2 (en) Modular endograft devices and associated systems and methods
US7655034B2 (en) Stent-graft with anchoring pins
EP1009325B1 (en) Bifurcated vascular graft and method and apparatus for deploying same
US20100305686A1 (en) Low-profile modular abdominal aortic aneurysm graft
US20070168013A1 (en) Vascular graft and deployment system
US20110093055A1 (en) Stent with segmented graft
AU2009286139A1 (en) Stent graft fixation coupling
US20240164890A1 (en) Stent graft
EP4356875A1 (en) Stent graft assembly
AU779171B2 (en) Kink resistant bifurcated prosthesis
AU2010326046B2 (en) Modular endograft devices and associated systems and methods
AU2007200974B2 (en) Kink resistant bifurcated prosthesis
AU2012203707A1 (en) Modular endograft devices and associated systems and methods
AU2004201997A1 (en) Kink resistant bifurcated prosthesis

Legal Events

Date Code Title Description
AS Assignment

Owner name: SILICON VALLEY BANK, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:ALTURA MEDICAL, INC.;REEL/FRAME:034704/0682

Effective date: 20141201

Owner name: SILICON VALLEY BANK, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:ALTURA MEDICAL, INC.;REEL/FRAME:034781/0718

Effective date: 20141201

AS Assignment

Owner name: ALTURA MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CRAGG, ANDREW H.;RIZK, ISA;SOSNOWSKI, STEPHEN;AND OTHERS;SIGNING DATES FROM 20140919 TO 20140923;REEL/FRAME:035246/0388

AS Assignment

Owner name: ALTURA MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CRAGG, ANDREW H.;RIZK, ISA;SOSNOWSKI, STEPHEN;AND OTHERS;SIGNING DATES FROM 20140919 TO 20140923;REEL/FRAME:035518/0256

AS Assignment

Owner name: ALTURA MEDICAL, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:SILICON VALLEY BANK;REEL/FRAME:036565/0660

Effective date: 20150730

AS Assignment

Owner name: ALTURA MEDICAL, INC., CALIFORNIA

Free format text: RELEASE;ASSIGNOR:SILICON VALLEY BANK;REEL/FRAME:036865/0590

Effective date: 20151007

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION